ENDPOINT_TYPE	DESCRIPTION	CHEMBL_STANDARDISED	ACTIVITY_COUNT	ASSAY_COUNT	BAO_TERM
Potency	Concentration or dose required to elicit a specific response	1	3029787	862	BAO_0000180?
pGI50	Negative logarithm of molar GI50	1	2446037	4411	BAO_0000189 (GI50)
IC50	Concentration required for 50% inhibition	1	2236874	98105	BAO_0000198 (relative IC50)?
MIC	Minimum inhibitory concentration	1	700540	46419
EC50	Effective concentration for 50% activity	1	508590	17215	BAO_0000188
Inhibition	Inhibition	1	501456	59162	BAO_0000201 (percent)
Activity	Activity	0	437953	128955	BAO_0001103 (percent)
Ki	Inhibition constant	1	393151	30263	BAO_0000192
ED50	Effective dose for 50% activity	1	169096	15722
GI50	Concentration required for 50% growth inhibition	1	128342	11082	BAO_0000189
AC50	Concentration required for 50% activity	1	114056	268	BAO_0000186
-Log Ki		0	107852	181	BAO_0000192 (Ki)
CC50	Concentration required for 50% cytotoxicity	1	83750	2417	BAO_0000187
Ratio	Ratio	0	64678	12814
Kd	Dissociation constant	1	61928	4438	BAO_0000034
MIC50	Minimum inhibitory concentration in 50% of population	1	41520	4414
IZ	Zone of inhibition	1	40550	5754
MIC90	Minimum inhibitory concentration in 90% of population	1	40396	4172
CL	Clearance	1	39490	5620
Ratio IC50		0	35659	5618
T1/2	Half-life	1	32392	10824
ID50	Dose required for 50% inhibition	1	30424	2377
pIC50	Negative logarithm of molar IC50	1	30022	1522
LC50	Concentration required for 50% lethality	1	29894	4463
TGI	Concentration required for total growth inhibition	1	23168	3629	BAO_0000194
Log Ki		0	21568	1871	BAO_0000192 (Ki)
Drug uptake	Drug uptake	0	21308	11017
GI	Growth Inhibition	0	19784	3140	BAO_0000096 (percent)
IFI	Inhibition Frequency (promiscuity) Index	1	19230	2
Cmax	Maximum concentration	1	19052	5272
Ratio Ki		0	16321	2009
Solubility	Solubility	1	16022	2641
IC90	Concentration required for 90% inhibition	1	15928	1026
pKi	Negative logarithm of molar Ki	1	14965	1135
LD50	Dose required for 50% lethality	1	14178	1235
F	Bioavailability	1	14138	5906
AUC	Area under curve	0	13812	6716
XC50	Concentration required for 50% effect	1	13562	20
MIC80	Minimum inhibitory concentration in 80% of population	1	12752	380
Efficacy	Efficacy	0	12414	1642
Fold change		0	12092	5721
LogP	Log(Partition Coefficient)	1	11670	1030
Selectivity		0	11507	1315
Selectivity ratio	Selectivity Ratio	0	11318	2440
T/C	Test/Control	0	11294	5282
Biodistribution		0	11060	5421
pA2	Negative logarithm of molar antagonist concentration giving agonist dose ratio = 2	1	10444	1662
Emax	Maximum efficacy	0	10242	1275
Change		0	9108	2158
Stability		0	8975	2195
pTGI	Negative logarithm of molar TGI	1	8945	3077	BAO_0000194
Log IC50		0	7808	765
Control		0	7662	2593
Ratio EC50		0	7342	1214
pKa	-log Ka	0	7329	1008
IC50_Mean		0	7289	22
Survived		0	7186	2956
Reduction		0	6982	1856
MBC	Minimum Bactericidal concentration	0	6577	1170
Selectivity index		0	6245	710
Vdss	Steady State Volume of Distribution	1	6214	2303
Time		0	6145	2165
Km	concentration of substrate that gives half-maximal activity	0	6139	1858	BAO_0000477
MCC	Minimum cytotoxic concentration	1	6138	308
Concentration		0	5868	2021
Stabilty	Stability	0	5542	1428
Relative potency		0	5538	737
Intrinsic activity	Intrinsic Activity	0	5462	547
Log EC50		0	5198	529
MFC	Minimum Fungicidal concentration	0	5188	799
Log D		0	4939	626
RBA	Relative Binding Affinity	0	4927	507
-Log EC50		0	4741	370
Papp	Apparent permeability	0	4692	803
ILS		0	4648	2138
MED	minimum effective dose	0	4602	696
Ratio CC50/EC50		0	4417	408
AC50_uM		0	4392	19
pLC50	Negative logarithm of molar LC50	1	4308	1865
permeability	Permeability	0	4206	686
Hepatotoxicity		0	3929	5
Log LC50		0	3735	978
CLogP	Calculated Log(Partition Coefficient)	1	3634	260
Log GI50		0	3529	1002
Dose		0	3519	837
FC	Fold Change	0	3496	969
Cytotoxicity		0	3467	501	BAO_0000006 (percent)
TI	Therapeutic Index	0	3279	434
TC50	Toxic concentration 50	0	3037	339
Decrease		0	3029	658
Tmax	Time for maximum concentration	1	3026	2124
pKb	-log Kb	0	2986	362
Kb	Equilibrium Binding constant	0	2912	483
Cures		0	2903	886
TD50	toxic dose affecting 50% of the population	0	2844	415
Ratio CC50/IC50		0	2814	186
MST	Median survival time	0	2745	856
EC50_Mean		0	2735	6
Relative activity		0	2621	375
Kcat	Catalytic constant	0	2592	602	BAO_0000481
Distribution		0	2551	1621
Ke	Equilibrium constant	0	2541	518
Kcat/Km		0	2495	543
Diet		0	2483	89
Kinact	Inactivation constant	0	2428	384
PD50	Protective Dose 50 (drug reqd. to cure 50% infected organism)	0	2415	359
logD	Distribution coefficient	0	2379	214
Protection		0	2360	592
Residual activity		0	2326	772
Vmax	Maximal velocity	0	2305	709	BAO_0000586
Log 1/C		0	2270	87
Cp	Plasma concentration	0	2270	1253
Increase		0	2252	698
Delta MST		0	2163	396
DIZ	Diameter of inhibition zone	0	2135	343
Thermal melting change		0	2121	321
IC95	Concentration required for 95% inhibition	1	2110	226
k obs/[I]		0	2059	289
EC90	Effective concentration 90	0	2011	332
Survival	Survival	0	2001	534
deltaTm	Change in melting temperature	0	1977	222
Effect		0	1933	824
pD2	Agonist potency	0	1907	369
Body weight change		0	1900	1109
pKB		0	1836	269
Vd	Volume of Distribution	1	1820	975
CLH	Hepatic clearance	0	1815	218
IC50 ratio		0	1787	268
SI		0	1721	253
Optimal dose		0	1697	230
Blood pressure		0	1672	529
pEC50	-log (EC50)	0	1653	105
Imax	Maximum inhibition	0	1640	229
Toxicity		0	1610	566
Max		0	1593	216
-Log MIC		0	1592	60
Ka	Association constant at equilibrium	0	1558	357
PPB	plasma protein binding	0	1546	546
MIC99	Minimum inhibitory concentration for 99% activity	0	1479	110
MTD	Maximum tolerated dose	0	1472	292
Plasma concentration		0	1469	657
Response		0	1465	522
Log K		0	1459	100
Log P		0	1451	180
Tm	Melting temperature	0	1425	213
Displacement		0	1405	224
MRT	Mean residence time	1	1388	475
Duration		0	1377	399
KB	Equilibrium Binding constant	0	1312	262
Log10 cfu		0	1267	896
Funbound_plasma		0	1252	286
K app		0	1244	128
Concentration @ Maxi		0	1244	1
CD50	50% Curative dose	0	1243	286
MEC	Minimum effective concentration	0	1219	226
Inhibition zone		0	1216	352
PI	Protection Index	0	1190	153
SUV	Standardized Uptake Value	0	1163	1068
Drug metabolism		0	1155	458
Blood pressure decrease		0	1146	288
K	Binding constant	0	1140	350
pKd	-log (Kd)	0	1089	96
Growth		0	1073	189
KA	Activation constant at equilibrium	0	1058	100
AD50	energy density necessary to induce apoptosis in 50% of the cells	0	1053	202
Conc @ Max Fold Incr		0	1040	1
T max		0	1036	482
Animals		0	1029	317
Stimulation		0	1013	249
IA		0	1005	156
%max	Maximum percentage	0	998	69
ED30	Effective dose for 30% activity	0	990	134
Blood pressure change		0	979	320
log(1/IC50)		0	977	23
Diuretic activity		0	926	304
ILS max		0	903	146
ED90	Effective dose 90	0	901	227
Selectivity Index	Selectivity Index	0	898	86
HepSE_hepatitis		0	888	1
HepSE_bilirubinemia		0	888	1
HepSE_cholecystitis		0	888	1
HepSE_liver disease		0	888	1
HepSE_cholelithiasis		0	888	1
HepSE_Combined Scores		0	888	1
HepSE_hepatic failure		0	888	1
HepSE_hepatic necrosis		0	888	1
HepSE_liver fatty		0	888	1
HepSE_elevated liver function tests		0	888	1
HepSE_liver function tests abnormal		0	888	1
HepSE_cirrhosis		0	888	1
HepSE_hepatomegaly		0	888	1
HepSE_jaundice		0	888	1
Therapeutic index		0	883	121
CL_renal	Renal clearance	1	876	160
Ratio ED50		0	864	161
Phospholipidosis		0	851	21
Mortality		0	795	403
Log 1/D50		0	792	3
Activation		0	783	119
Log 1/LD10		0	776	1
logGI50		0	767	139
Potency ratio		0	762	116
Inhibition rate		0	753	92
C50	Concentration required for 50% decrease in initial absorbance of DNA	0	750	97
Reversal		0	747	89
Level		0	744	407
IC80	Concentration required for 80% inhibition	0	740	76	BAO_0000191
Radioactivity level		0	738	394
Binding		0	737	245
Relative binding affinity		0	735	41
solubility	Solubility	0	699	179
log10CFU/ml	log10 colony forming unit per 1 ml	0	696	597
Mean arterial blood pressure change		0	690	230
Suppression		0	677	137
K ass		0	672	83
Max response		0	671	97
Blood pressure decrease (max)		0	670	90
Systolic blood pressure decrease		0	670	205
AC40		0	669	1
fT>MIC	Percentage of time that the free-drug concentration exceeds the MIC for the test pathogen	0	669	623
Heart rate		0	668	333
%Bound_plasma		0	668	235
ED	Effective dose	0	667	103
MTC	minimum toxic concentration	0	661	55
Mean survival time (change)		0	649	9
Recovery		0	628	232
MIC100	Minimum Inhibitory concentration for 100% activity	0	626	74
Ratio IC50/EC50		0	622	84
Cholesterol (total change)		0	621	38
Log 1/MMIC		0	612	16
Clearance		0	605	205
AbsAC40_uM		0	597	2
HR		0	590	213
MPC	Minimum Protective Concentration	0	589	145
ED20	Effective dose for 20% activity	0	585	67
k cat		0	584	192
Viability		0	576	150
Variation		0	569	60
Delta Tm		0	566	65
ID		0	563	194
Affinity		0	560	79
Locomotor activity		0	560	194
Vss		0	554	295
fu		0	554	1
k3/Ki		0	544	16
Log2 MIC		0	543	24
Activity rating		0	531	117
EDmin		0	531	56
Fu	percent free drug in tissue	0	527	201
CD	Drug concentration required to double induction	0	521	32
IC100	Inhibitory concentration for 100% activity	0	519	73
Virus rating		0	519	162
EC	Effective concentration	0	516	44
Mean survival days		0	509	185
Temperature change		0	509	166
Ratio pKi	Ratio (-log Ki)	0	507	58
Heart rate change		0	505	181
AbsAC1000_uM		0	505	1
Delta IOP		0	499	231
Uptake		0	498	217
Log k'		0	493	31
Relative IC50		0	492	84
Composite Activity - Marginal		0	490	1
GGT Increase - Activity Score		0	490	1
LDH Increase - Activity Score		0	490	1
SGOT Increase - Activity Score		0	490	1
SGPT Increase - Activity Score		0	490	1
GGT Increase - Number of Reports		0	490	1
LDH Increase - Number of Reports		0	490	1
SGOT Increase - Number of Reports		0	490	1
SGPT Increase - Number of Reports		0	490	1
Alkaline Phosphatase Increase - Index Value		0	490	1
Alkaline Phosphatase Increase - Activity Score		0	490	1
Alkaline Phosphatase Increase - Number of Reports		0	490	1
SGPT Increase - Index Value		0	490	1
SGOT Increase - Index Value		0	490	1
Composite Activity - Active		0	490	1
LDH Increase - Index Value		0	490	1
GGT Increase - Index Value		0	490	1
Composite Activity - Score		0	490	1
Saluretic activity		0	485	48
Concentration_plasma		0	482	360
HD50	Dose required for 50% hemolysis	0	482	55
T-C		0	482	234
UI	Ulcer index	0	478	111
Therm_solubility	Thermodynamic solubility	0	477	55
Paw swelling		0	477	174
BPR	Brain plasma ratio	0	477	196
ED25	Effective dose for 25% activity	0	476	92
Growth Inhibition		0	469	150	BAO_0000096 (percent)
-Log C		0	465	23
Binding affinity		0	464	56
Clp		0	464	158
EC25	Effective concentration for 25% activity	0	462	53
Log 1/Ki app		0	458	11
RatioGI50		0	451	88
Inflection point		0	450	18
Fall		0	443	75
Ki ratio		0	442	114
Ratio TD50/ED50		0	440	60
Anticonvulsant activity		0	440	88
log Ks	Binding constant	0	435	69
INH	Inhibition	0	435	122
Rm		0	433	30
Relative affinity		0	429	55
Permeability		0	426	54
Body weight change (mean)		0	424	235
Score		0	421	88
Log (1/C)		0	421	12
K inact		0	417	144
APTT	Activated Partial Thromboplastin Time	0	416	101
Kis	Inhibitor dissociation constant in which the inhibitor affects the slope of the double reciprocal plot	0	416	71
PB	Protein binding	0	411	163
-logMIC	-log MIC	0	410	24
FICI	Fractional Inhibitory concentration index	0	410	215
k		0	406	120
Kinetic_solubility		0	404	41
Urine volume		0	404	211
EC30	Effective concentration for 30% activity	0	403	62
Block		0	403	90
Weight		0	401	196
logK		0	399	35
Dead		0	397	256
-Log KB		0	397	33
deltaCT		0	396	234
Retention time		0	394	72
Log D7.4		0	392	19
LogP app		0	391	13
K obs		0	387	150
Body weight		0	386	204
Bmax	maximum binding	0	384	257	BAO_0000033
CFU	Colony forming units	0	377	318
Effective dose		0	376	77
pD'2	antagonistic affinity	0	371	9
k2		0	367	69
Diameter of inhibition zone		0	366	107
KE		0	359	216
Incorporated		0	356	187
Fa	Oral absorption	0	356	13
AUC/dose	Area under curve/dose	0	356	119
Hill coefficient		0	355	53
RA		0	354	33
CL/F	Clearance/Bioavailability	1	354	294
Solubility ratio		0	353	17
Mean survival time		0	353	129
SDL		0	351	263
Cooperativity		0	350	42
Viable cells		0	350	90
k'		0	345	26
EC50_MICROM		0	344	16
LD10	lethal dose for 10% activity	0	343	36
MBC90	Minimum Bactericidal concentration for 90% activity	0	342	73
Release		0	339	50
Schizont size		0	339	1
Log		0	338	23
Metabolism		0	336	83
Average weight		0	334	139
Ratio AUC		0	333	173
Distribution of radioactivity		0	330	104
pED50	-log DZ50	0	329	27
Resistance index		0	328	41
MPC8		0	328	24
Log D6.5		0	327	6
Blood glucose		0	324	47
Tumors		0	324	277
Kapp	Apparent binding constant	0	323	75
PFA		0	323	139
NT		0	322	52
LD99	Lethal dose for 99% activity	0	322	54
Safety ratio		0	322	27
No. of revertants per plate		0	320	41
IC20	Inhibitory concentration for 20% activity	0	319	43
Specific activity		0	319	63
pKa2		0	318	71
Antagonism		0	317	90
Fh	Hepatic availability	0	316	2
Cmin	Minimum concentration	0	316	306
PT	Prothrombin time	0	315	48
2PT	2(Prothrombin Time)	0	314	24
ED40	Effective dose for 40% activity	0	313	39
Log10LC50	Log10 (Lethal Concentration for 50% activity)	0	308	247
Fg	Fraction escaping gut-wall elimination	0	308	1
Cell number		0	308	126
MBC50	Minimum Bactericidal concentration for 50% activity	0	307	67
Mean injected dose/g		0	307	87
Weight difference		0	307	93
MES		0	306	44
MLC	Minimum Lethal Concentration	0	305	36
P		0	303	34
Polyamine		0	302	157
k cat/Km		0	301	76
LCK	Log10 cell kill	0	299	190
ED50 ratio		0	299	111
pKa1		0	299	55
APD95		0	299	94
log(10^6/IC50)		0	297	6
Relaxation		0	296	36
Remaining		0	295	55
IC12	Concentration required for 12% activity	0	294	77
MIC95	Minimum inhibitory concentration for 95% activity	0	291	53
Log 1/M		0	291	9
Max inhibition		0	290	78
Complex formation		0	290	22
Log Pe		0	289	17
CCIC50	Cell culture 50% inhibitory concentration	0	289	11
Kii	Inhibitor dissociation constant in which the inhibitor affects the intercept of the double reciprocal plot	0	289	46
PC50	Preferential cytotoxicity 50%	0	289	28
VR		0	289	83
HC50	Concentration required for 50% hemolysis	0	289	23
Drug release		0	288	14
LTKB_BD DILI severity score		0	286	3
IC99	Concentration required for 99% inhibition	1	284	15
D	Diffusion coefficient	0	284	194
Analgesia		0	283	44
Relative efficacy		0	282	39
Blood pressure change (mean)		0	279	131
log IC50		0	278	21
Post antibiotic effect		0	278	268
pKD		0	278	46
Oral activity		0	274	94
Average IC90		0	273	8
Accumulation		0	273	118
Delta logD		0	272	6
Rate		0	270	90
IC30	Inhibitory concentration for 30% acitivity	0	270	43
log(1/Ki)		0	269	12
R		0	269	32
Formation		0	267	69
Cell growth		0	267	111
Hydrolysis		0	267	52
Brain/Plasma ratio		0	267	129
RUmax	Response Unit Maximum	0	266	28
MBIC	Minimum biofilm inhibitory concentration	0	265	72
Cell survived		0	265	51
D50	Half-maximal effective dose	0	265	23
LTS		0	263	186
Cell death		0	263	112
Delta G		0	263	10
Log 1/EC50		0	262	12
log(1/ID50)		0	261	11
DILI positive/negative		0	261	3
Motility		0	260	160
Fold reversion		0	258	11
Range		0	258	228
ED1.5		0	257	13
Rmax		0	256	58
IC25	Concentration required for 25% activity	0	256	38
Amnesia reversal		0	255	22
Emetic episodes		0	254	108
RF		0	253	54
Estrogenic effect		0	253	34
Intraocular pressure		0	253	81
ED100	Effective dose for 100% activity	0	253	75
Residual insulin release		0	252	34
Excreted		0	248	125
AP		0	248	99
Relative Vmax		0	247	58	BAO_0000586 (vmax)?
IG50	50% inhibition of growth	0	247	42
Tissue distribution		0	245	170
Ratio Ke		0	244	21
fAUC/MIC	Free Area under the concentration time curve/Minimum Inhibitory Concentration	0	243	223
Potentiation		0	242	22
Toxic deaths		0	241	149
kinact		0	241	62
I		0	240	54
Binding energy		0	239	6
Median survival time		0	239	182
No. of mice		0	238	88
-log(1/MIC)		0	238	10
MSD	Mean survival Days	0	238	97
TCS50	Lethal to 50% of the tumor cells	0	238	41
Antagonist potency		0	237	39
pI50	-log (Inhibitory concentration for 50% activity)	0	237	11
K0.5	Half maximal binding constant	0	236	29
-Log IC50		0	236	27
Max activation		0	235	19
Survival time		0	235	149
Kon		0	234	53	BAO_0000480
EC80	Effective concentration for 80% activity	0	234	22
Rate constant (k)		0	234	59
Partition coefficient		0	232	42
EC20	Effective concentration for 20% activity	0	231	37
ALD50	Approximate lethal dose 50	0	231	18
Parasitaemia		0	230	42
LC99		0	229	20
Glucose normalisation		0	227	44
Mole fraction		0	227	4
Brain concentration		0	227	195
IC70	Inhibitory concentration for 70% activity	0	226	123
Aggregate		0	226	68
Retention		0	226	34
Lethality		0	225	137
Systolic blood pressure change		0	225	58
Log10 CFU/ml		0	225	164
pCC50	-log (CC50)	0	225	9
Hypoglycemic activity		0	224	25
Cell viability		0	224	46
MNEC	maximum non-effective concentartion	0	223	13
Max stimulation		0	223	24
K2		0	222	46
CC90	Cytotoxic concentration for 90% activity	0	222	26
Ratio pIC50		0	221	30
DNAUC		0	220	4
CMC	Critical micelle concentration	0	220	29
CF		0	218	19
Drug degradation		0	218	71
Log SP		0	217	5
Relative uterine weight		0	217	59
Efficiency		0	216	82
Sleep time		0	216	48
MAP		0	214	102
Mean survival		0	213	55
TPE		0	213	50
Fluorescence Intensity		0	212	82
Log RA		0	211	1
nH		0	211	35
NA		0	211	66
Agonistic potency		0	210	27
Smax	Maximum Stimulation	0	208	35
t1/2	Half life	0	205	58
MPE	Maximum possible effect	0	205	84
Max effect		0	205	36
Na		0	204	156
Acquisition time		0	204	44
BWD		0	203	116
Ks	Spectral dissociation constant	0	203	70
LD90	Lethal dose for 90% activity	0	203	49
Basal uptake		0	202	34
Diuretic effect		0	201	66
Index		0	201	12
Enhancement		0	201	36
Delta -LogIC50 wt-mutant		0	200	8
P50		0	200	40
MGM		0	200	13
Protected		0	200	63
Mean arterial blood pressure		0	199	78
Log kill		0	199	85
Log 1/K		0	198	10
Na+ excretion		0	198	131
Taste character		0	198	143
CT		0	197	77
GABA ratio		0	196	17
Blood glucose change		0	196	39
deltaT	Change in temperature	0	196	79
V		0	195	157
TDS		0	195	125
Change in amplitude response		0	193	82
MFC90	Minimal Fungicidal Concentration 90	0	192	56
Relative SEAP activity		0	192	73
Relative viability		0	192	72
IP	Inflection point for test compound to inhibit binding of radioligand	0	191	37
Km app		0	190	33
C10	Concentration giving a surviving fraction of 10%	0	189	25
log Kp	Permeability coefficient	0	189	5
PGI		0	189	42
Delta A/min		0	188	38
C20		0	188	19
AB50		0	187	48
Log 1/MIC		0	187	13
PF50	Potentiation factor 50	0	187	37
Resistance		0	186	32
logPapp	log (apparent permeability)	0	185	5
Ct	Drug concentration in Tissue	0	185	121
Vz	Apparent volume of distribution	0	183	88
Log PNalk		0	182	1
EC50 ratio		0	182	19
Relative rate of hydrolysis		0	181	32
Reversion		0	180	25
EC99	Effective concentration for 99% activit	0	179	23
MPR		0	178	17
Specific binding		0	178	54
MTL		0	178	9
RRT		0	177	33
Fold selectivity		0	177	27
Log 1/T		0	177	6
Geometric mean		0	176	19
k3/ki		0	176	7
Cleavage		0	175	90
Log TGI		0	174	60	BAO_0000194 (tgi)
Taq inhibition		0	174	29
-Log ED50		0	174	16
SVT		0	173	26
pIC25	-log (IC25)	0	172	11
Latency		0	172	79
GE		0	171	32
Disease control		0	171	25
Lowering		0	171	83
ERH	Hepatic Extraction Ratio	0	170	21
Tumor volume		0	170	84
Number		0	170	105
MAC	minimum active concentration	0	170	25
Total radioactivity		0	169	84
GABA shift		0	169	9
Uterine weight		0	168	60
CFU/ml	Colony forming units per ml	0	168	164
pK		0	167	17
FRP		0	166	54
Average skin reaction		0	166	30
Serum Ca2+		0	166	61
Contraction		0	165	32
MFC50	Minimal Fungicidal Concentration 50	0	165	29
Koff		0	164	41	BAO_0000479
TC		0	164	90
Normalization		0	163	13
Absorption		0	162	56
In Vivo Blockade of [123I]1 Uptake		0	162	125
Response ratio		0	162	3
Parasitemia		0	162	72
Growth_index	Growth index	0	161	27
2aPTT	2(Activated Partial Thromboplastin Time)	0	160	16
No. sensitive		0	160	24
Inhibition (radial growth)		0	160	16
Agonist activity		0	160	58
Conversion		0	160	30
QH	Hepatic blood flow	0	159	85
log10(%HIA)		0	159	1
Duration of action		0	159	59
Resistance factor		0	159	14
Average CC50		0	159	12
Log kon		0	158	1	BAO_0000480 (kon)
Allosteric enhancer (AE)		0	158	12
Animals protected/total		0	158	97
RIS		0	158	7
kHOX		0	157	16
Survived/total		0	157	113
Relative ED50		0	157	27
Zone size		0	157	56
Iron change		0	156	112
Proliferative response		0	156	16
No. of mice protected		0	156	71
MISS T/C		0	156	4
ED2		0	155	20
Log kOH-		0	155	2
-Delta G		0	155	6
Kic	Competitive inhibition constant	0	154	30
Uptake ratio		0	154	30
deltaA	Change in absorbance	0	154	11
MBIC90		0	154	39
CLp		0	153	67
HACU improvement		0	153	6
EC100	Effective concentration for 100% activity	0	153	12
kon		0	152	16	BAO_0000480
Reduction of live worms		0	152	27
K inact/Ki		0	152	31
ISA		0	151	10
Systolic blood pressure		0	151	55
Neurotoxicity		0	151	18
pRA		0	150	3
CT10		0	150	21
K+ excretion		0	150	90
CC100	Concentration required for 100% cytotoxicity	0	150	19
Culture		0	150	56
MNTD	Maximal non-toxic dose	0	149	13
Turnover		0	149	24
Saluretic potency		0	149	15
Inhibition ratio		0	149	59
Survivors at day 4		0	149	38
LAD		0	148	13
Apoptosis		0	148	40
Absorbance		0	148	26
HF		0	147	13
Oral diuretic activity		0	147	15
Phytotoxicity		0	147	42
CLogD	Calculated Log(Distribution Coefficient)	1	147	9
Relative EC30		0	145	36
RatioAUC/MIC		0	145	144
Average survived		0	145	79
Activity scale		0	145	17
Vmax/Km		0	144	56
Mean relative potency		0	144	5
Licking latency		0	144	69
AUCt		0	143	76
TT	Thrombin time	0	143	21
Antiovulatory activity		0	143	48
MNCC	Maximal non-cytotoxic concentration	0	143	15
Swelling		0	143	72
Delta T		0	143	66
EC15	Effective concentration for 15% activity	0	142	10
Blood pressure increase		0	142	48
Behavior		0	142	27
2x aPTT		0	141	22
Fold induction		0	141	20
BBC	BIOFILM BACTERICIDAL CONCENTRATION	0	140	20
CHI	Chromatographic hydrophobicity index	0	140	10
Weight loss		0	140	86
log K	Partition coefficient	0	140	10
HCR		0	140	9
logIC50		0	139	11
Ki app		0	138	23
P50e		0	138	10
Leishmanicidal activity		0	138	41
Survival rate		0	138	35
CPE index		0	138	3
Toxic		0	137	42
Temperature		0	137	46
C/I ratio		0	137	94
dP/dt		0	136	56
Proliferation		0	136	13
kDPPH		0	136	6
UTC		0	135	6
SC50	Shift concentration 50, Concentration required for 50% DNA band shift	0	135	16
Log10TGI	Log10 (Tumor growth inhibition)	0	135	132
Blood pressure (mean)		0	135	69
Recovery time		0	135	52
Normal beats		0	135	6
No. of toxic deaths		0	135	15
Rating		0	135	17
Toxic dose		0	134	27
Change in IOP		0	134	85
Log koff		0	134	1	BAO_0000479 (koff)
CCh		0	133	26
GC50	Concentration for 50% reduction of cell viablity	0	133	11
Cholesterol level		0	133	49
Hypersensitivity factor		0	133	9
No. of positive cases		0	133	6
Equieffective dose		0	132	7
Log 1/I50		0	130	13
Log BR		0	130	6
Fold increase		0	130	22
Tumor weight		0	130	91
Amount excreted		0	130	9
Mutagenicity		0	129	59
KB app		0	129	11
MAD		0	128	16
KL		0	128	24
Glycaemia evolution		0	128	9
Reversion activity		0	128	43
Time constant		0	128	23
Agonism		0	128	7
EMR	Equieffective molar ratio	0	127	16
Activity decrease		0	127	18
Toxicity ratio		0	127	6
Max salt tolerance		0	126	9
Metabolite levels		0	126	86
Ratio_brain/plasma		0	126	74
p[A50]		0	125	26
Relative velocity		0	125	21
Plasma binding		0	125	55
Activity index		0	125	35
MD		0	124	32
Fluorescence		0	124	11
AUClast	Area under the plasma concentration-time curve up to the last quantifiable time-point	0	124	87
logP(lung)		0	124	5
pKA	-log Ka	0	123	22
TCID50	Tissue culture infective dose 50	0	123	43
Arterial blood pressure change		0	123	42
Serum level		0	123	110
Methemoglobin		0	123	22
Enzyme activity		0	123	26
kOX		0	122	13
HI	Hemolytic index	0	122	5
Log 1/MEC		0	122	2
Hemolysis		0	122	28
EC150	Effective concentration for 150% activity	0	122	10
TR		0	121	9
Lysis		0	121	14
logFu	log of percent free drug in tissue	0	121	1
Body weight change difference		0	121	35
Life span increase		0	121	81
Relative amplitude		0	121	16
Inhibition potency		0	121	22
k obs		0	120	67
Susceptibility		0	120	20
Alpha max	Maximal increase in activity	0	120	9
Antagonist activity		0	119	62
Log10GI50	Log10 (Concentration for 50% growth inhibition)	0	119	119
ND50		0	118	40
Stimulation index		0	118	22
Volume		0	118	49
ED99	Effective dose for 99% activity	0	117	23
Blood sugar lowering		0	117	21
Log 1/Km		0	117	3
Increase in MST		0	116	71
LD0		0	115	14
Count		0	115	36
Log ED50		0	115	10
Cardiac rhythm decrease		0	115	39
Metabolic stability		0	115	14
Change in Cl- current		0	115	6
Mean survival time (increase)		0	115	29
SMT		0	114	20
Mean		0	114	86
TDI	Time dependent inhibition	0	114	28
RLU		0	113	16
SD90		0	113	10
Cholesterol reduction		0	113	12
Induction		0	113	27
Conversion rate		0	113	29
Secretion		0	113	16
Rf		0	112	3
T50	Half time of compound degradation	0	112	21
T	Temperature	0	112	36
Selectivity quotient		0	112	11
Glucose utilization		0	112	1
Inhibitory diameter		0	112	71
OD	Optical density	0	112	6
Q		0	111	6
RFU	Relative Fluorescent Unit	0	111	29
mechanism based inhibition		0	111	78
Production		0	111	55
t1/2(app)		0	111	29
SP		0	110	5
ED10		0	110	26
CI		0	110	50
Agonist effect (% of maximal  increase)		0	110	32
log10CFU/g	log10CFU/g	0	110	100
Entry latency		0	110	27
Pc		0	110	10
pTD50	-logTD50	0	109	2
Fold activation		0	109	17
pKa3		0	109	38
DD		0	108	6
Na+/K+		0	108	14
Antiviral activity		0	108	37
deltalog10CFU/ml	delta log10 colony forming units per ml	0	108	54
Total iron output		0	108	18
Taste class		0	108	3
IVP		0	107	3
IR		0	107	67
Safety index		0	107	15
Expression		0	107	23
T/C x100		0	107	61
TI50		0	107	19
CC25	Cytotoxic concentration for 25% activity	0	106	23
Protein binding		0	106	18
No. of rosettes/100 Jurkat T cells		0	106	15
Heart rate change (at D50 dose)		0	106	3
Sensitivity		0	106	56
MPE50		0	105	15
Onset		0	105	13
Inhibitory index		0	105	6
Max reversal		0	105	55
Estrogenic potency		0	105	7
MBC99.9	Minimum Bactericidal concentration for 99.9% activity	0	104	4
ID90	Inhibitory dose 90	0	104	21
Antifertility potency		0	104	3
Serum concentration		0	104	27
Wet weight of tissue		0	104	104
LD20	Lethal dose for 20% activity	0	104	5
LED	Lowest effective dose	0	103	13
Log I50		0	103	4
Relative protection		0	103	9
Log Pn		0	103	7
TG100		0	103	10
IS		0	102	12
PC		0	102	12
Protein-DNA complex formation		0	102	1
PBI		0	102	36
Beta2 duration		0	102	1
ECmax	Concentration needed to induce maximal response	0	102	10
A50	Dose required for 50% antinociceptive effect	0	101	44
P50c		0	101	4
ID50 ratio		0	101	4
Affinity constant		0	101	12
log(ratioKi)		0	101	1
Mean arterial blood pressure decrease		0	101	33
Blood level		0	101	78
RE		0	100	11
K1		0	100	30
MID	Minimum inhibitory dose	0	100	23
Change in response		0	99	36
Adhesion		0	99	6
Funbound_brain		0	99	26
Protective index		0	99	14
Body weight reduction		0	98	65
Average dose per organ		0	98	98
Amount of TNF-alpha		0	98	7
NO release		0	98	10
Hammett constant		0	98	2
IC50 increase		0	98	13
Hypothermic effect		0	98	41
Benzidine positive cells		0	97	24
PCMA antagonism		0	97	34
BK		0	97	13
BA		0	97	28
ED15	Effective dose for 15% activity	0	97	17
Transfection efficiency		0	96	8
Serosal/Mucosal Ca		0	96	36
Sweetness potency		0	96	78
Total cholesterol		0	96	34
pka		0	96	8
logKw	lipophilicity parameter	0	96	7
HDL-C		0	96	39
koff		0	96	17	BAO_0000479
ED95	Effective dose for 95% activity	0	96	19
Lactone		0	96	25
Urinary recovery		0	95	11
Liver weight		0	95	36
3 log kill		0	95	2
DA release		0	95	2
Cp(f)	Free plasma concentration	0	95	41
CCID50	Cell culture infective dose 50	0	95	7
Log K'		0	95	1
Taste		0	95	32
Ataxia		0	95	33
Plaque reduction		0	94	86
Animals survived		0	94	52
Radiation prot		0	94	4
MLD	Minimal Lethal Dose	0	94	17
Log 1/D40		0	94	5
LD100	Lethal dose for 100% activity	0	94	19
IC10	Concentration required for 10% inhibition	0	94	14
H2O2 prot		0	94	3
log(1/EC50)		0	93	3
Extracted		0	93	24
Kp	Permeability coefficient	0	93	10
APD		0	93	19
Cells		0	93	41
Mean aortic blood pressure		0	92	43
Increase in ear thickness		0	92	7
Differentiation		0	92	37
FIC50	Fractional Inhibitory concentration given by IC50(drug combo)/IC50(drug)	0	92	64
Max decrease		0	92	23
Blood flow		0	92	46
log Pe	Permeability coefficient	0	92	8
Zone diameter		0	92	12
Relative resistance		0	91	9
kin		0	91	18
Cl- excretion		0	91	80
Survival ratio		0	91	21
Cl- excretion (mean)		0	90	6
Na+ excretion (mean)		0	90	6
K+ excretion (mean)		0	90	6
Biliary excretion		0	90	8
Mean urine volume		0	90	8
Polyamine level		0	90	60
Am		0	90	12
K 0.5		0	90	11
ED80	Effective dose for 80% activity	0	90	25
LDH		0	90	10
RP		0	90	10
A10		0	90	1
Average consumed		0	90	90
Distribution coefficient		0	89	7
p[A]50		0	89	6
REC		0	89	7
LC100	Drug concentration causing 100% death of test organisms	0	89	17
ki/Ki		0	89	22
Plasma cholesterol change		0	88	22
Increase in concentration		0	88	26
Blockage activity		0	88	62
Delta log10CFU/ml		0	88	88
Kinetic constant		0	88	35
Nuclear cataract		0	88	44
BWC		0	88	74
Mean logD		0	88	4
Delta TC		0	88	27
CCTD50		0	88	1
pK1		0	88	21
PDK		0	88	48
ACT		0	88	18
Ratio AUC/MIC		0	88	88
Glucose transport		0	87	3
Ovulating rats		0	87	75
Judgments		0	87	31
Esc loss		0	87	3
DOM		0	87	45
ED200		0	87	19
Loss		0	87	29
RAC		0	87	5
Slope		0	87	21
No. of rats ovulated		0	86	65
Therapeutic ratio		0	86	13
Active dose range		0	86	63
Mean tumor volume		0	86	67
HYPO		0	86	12
Delta APD95		0	86	19
Delta Vmax		0	86	16
Result		0	86	80
Revertants/plate		0	86	48
Protection index		0	85	12
Antibacterial activity		0	85	6
Hepatic Extraction ratio		0	84	6
Blood glucose decrease		0	84	6
Antitumour activity		0	84	35
Binding intensity		0	84	9
ov. rat/total		0	84	58
DNA cleavage		0	84	14
DRF		0	84	9
Log 1/Ki		0	84	3
C20 APD95		0	84	21
EII50		0	84	4
pA10	Negative logarithm of antagonist concentration producing 10-fold shift in agonist curve	0	84	12
Ki''		0	84	11
LLR score		0	84	39
Relative JC-1 accumulation		0	83	3
CC		0	83	21
Survival days		0	83	70
Saldiuretic activity		0	83	54
No. of Colony forming Units		0	82	16
Relative inhibition		0	82	10
Fibril formation		0	82	2
p(1/MIC)	-log (1/MIC)	0	82	1
NS		0	82	33
pIC100		0	82	1
LTC		0	82	5
RSA	Relative Stimulatory Activity	0	82	7
FIC		0	82	14
Synergy		0	82	10
Antidiuretic activity		0	81	15
Relative activation		0	81	26
Toxic level		0	81	23
ND		0	81	25
Vc/F	Apparent volume of distribution with respect to the bioavailability	0	81	75
MHC	Minimal hemolytic concentration	0	81	10
Ki'		0	81	22
scMet		0	81	16
Mycelial growth		0	80	10
Relative amount		0	80	49
Lipid level		0	80	67
ALP activity		0	80	9
CMP		0	80	10
Kd app		0	80	11
logRA	log (relative activity)	0	80	1
ED300		0	80	14
IAr		0	80	7
T/C max		0	80	36
Inactivation		0	79	32
Latency time		0	79	10
K cat		0	79	19
ECS ratio		0	79	8
Log BB		0	79	6
Mean weight		0	79	17
Systolic blood pressure (base-line)		0	78	3
log10CCID50	log10 cell culture infective dose 50	0	78	54
x fold		0	78	10
MI0.5		0	78	9
NI		0	78	23
BBR	Blood Brain Ratio	0	78	31
AA		0	78	7
IF		0	78	7
LC90	Drug concentration causing 90% death of test organisms	0	78	12
Loss of righting reflex		0	77	5
Accumulated counts		0	77	42
Pm	Intrinsic permeability	0	77	23
MMC	Minimum metabolic activity concentration	0	77	18
Peak rhGH		0	77	10
Heart rate decrease (max)		0	76	17
GS		0	76	3
Antibiotic activity		0	76	16
Inhibition response		0	76	2
Uterine activity		0	76	8
Fold resistance		0	76	36
Triglycerides		0	76	18
Growth zone		0	76	23
TI rating		0	76	3
Life span		0	76	52
Log Kmemb		0	76	1
IC200	Concentration required for 200% activity	0	76	9
TGIR		0	76	33
pKa4		0	76	25
Krel		0	76	27
Temperature decrease		0	76	28
Relative agonistic activity		0	75	15
2-DG uptake stimulation		0	75	3
Relative stability		0	75	8
Log potency ratio		0	75	8
HSAI		0	75	1
Log Kd		0	75	28
RD500		0	75	26
CyD50		0	75	2
XI50	Surface concentration of the inhibitor for 50% inhibition	0	75	10
K(p,uu,CSF)		0	75	2
Blood pressure change (max)		0	74	22
Uterotrophic effect		0	74	16
Plasma glucose level		0	74	24
MGC		0	74	6
Cured/treated		0	74	49
EC200		0	74	5
MDD		0	74	53
Interferon response		0	74	13
Drug discrimination effect		0	73	11
No. of rabbits convulsed		0	73	45
Hill coefficient (n50)		0	73	2
Remaining activity		0	73	4
Ratio Ki(app)		0	73	34
Bioreduction		0	73	43
FR		0	73	12
Ki 0.5		0	73	10
CT50	Wound Half closure time	0	73	19
IC5	Concentration required for 5% inhibition	0	73	11
Kel	Elimination rate constant	0	73	50
E		0	73	13
Log [MrI]		0	73	1
Excretion rate		0	72	23
TBPS shift		0	72	4
Convulsion		0	72	15
Delta logP		0	72	9
LS		0	72	2
Log A		0	72	5
pK2		0	72	9
Kin	Blood-brain transfer coefficient	0	72	16
Log KD		0	72	2
Mouse behavior activity		0	71	25
Inhibitor level		0	71	8
Organ weight		0	71	31
Log10 GI50		0	71	68
Degradation		0	71	17
K bind		0	71	10
PF	Potentiation factor	0	71	2
Lw/Bw		0	71	3
Shift		0	71	10
logPF	log of Potentiation factor	0	71	2
Pmax		0	71	7
Cr		0	71	51
FA		0	71	4
Log CR		0	71	10
Serum cholesterol		0	70	25
Ulcerogenic index		0	70	58
Relative growth		0	70	51
Acute toxicity		0	70	47
Log cell kill		0	70	34
Log k'w		0	70	3
UR		0	70	24
logS0	log of intrinsic solubility	0	70	1
Ki/KI		0	70	10
Peff		0	70	8
p24		0	70	10
GHI		0	70	1
Ka'		0	70	1
logKA	Relative binding affinity constant	0	70	4
Change in reaction time		0	69	27
Biological activity		0	69	7
Collapse time		0	69	3
Drug level		0	69	37
MCC50		0	69	18
UN		0	69	48
APD75		0	69	9
MET	Metabolism	0	69	4
RPP		0	69	19
SS		0	69	1
pMIC		0	69	5
Relative Fluorescent Unit		0	68	23
Fraction free drug in plasma		0	68	3
Vasorelaxant effect		0	68	14
Cholesterol change		0	68	32
Log relative k'		0	68	1
Diameter		0	68	31
C		0	68	14
C1.6		0	68	9
PCA		0	68	30
G30		0	68	3
I50	Inhibitory concentration for 50% activity	0	68	24
R%	Membrane retention	0	68	2
pC1		0	68	3
[3H] concentration		0	67	32
Parasite_Clearance		0	67	29
Mean peak APTT		0	67	1
No. of chicks		0	67	29
Lethal dose		0	67	12
RIA		0	67	6
Incidence		0	67	56
GDP ED50		0	67	5
Length		0	67	50
ED150		0	67	2
PI turnover		0	67	8
Decrease in QA interval		0	66	23
TG		0	66	24
Median survival		0	66	56
Ulcer incidence		0	66	45
Binding activity		0	66	26
Edema variation		0	66	25
Glucose level		0	66	40
Max reduction		0	66	16
Growth delay		0	66	54
Iron output		0	66	22
Ratio_Papp		0	66	2
-Log ID50		0	66	4
BWLmax		0	66	45
CD100		0	66	2
Edema		0	66	43
P50d		0	66	1
EC2x		0	66	5
ED85	Effective dose for 85% activity	0	66	6
[I]		0	66	8
MOT		0	66	9
Analgesic efficacy		0	66	17
Tumor area change		0	65	54
Potency_Clk4_uM		0	65	1
Deaths/total		0	65	37
Log kw		0	65	4
ka	Absorption rate constant	0	65	59
MBEC	Microbial biofilm eradicating concentration	0	65	26
cAMP		0	65	7
SRR		0	65	11
MFC99		0	65	5
Mean arterial blood pressure change (max)		0	64	24
Kr	Binding affinity at resting state	0	64	15
Fraction unbound in tissue		0	64	1
Residual insulin secretion		0	64	4
Discrimination ratio		0	64	5
Fraction ionised		0	64	1
Rotarod toxicity		0	64	13
Behavioral score		0	64	27
Binding constant		0	64	16
STY seizure		0	64	4
Delta HDL		0	64	2
Tracer		0	64	16
Amount		0	64	30
Log k		0	64	11
Bound		0	64	17
ElogD		0	64	1
EC5X		0	64	5
RBF		0	64	26
CPA		0	64	3
ITP		0	64	6
AC3		0	64	4
Radius of inhibition zone		0	64	8
Cl - current change		0	63	3
Animals protected		0	63	26
Inhibition uptake		0	63	36
Activity ratio		0	63	11
AUBC	Area under the bactericidal curve	0	63	63
AZT formation		0	63	6
-Log KD		0	63	11
T>MIC	Time during which total drug concentration exceeds the MIC for the test pathogen	0	63	63
I ABC		0	63	6
Log activity		0	63	1
Ulcerogenic activity		0	62	14
Max non-toxic dose		0	62	2
cAMP accumulation		0	62	14
Transactivation		0	62	4
Hydrolysis rate		0	62	18
Weight gain		0	62	47
TN		0	62	4
Log RAI		0	62	2
AUC N		0	62	10
Ki/Km		0	62	23
PHA		0	62	24
EC5	Effective concentration for 5% activity	0	62	9
Vmax(app)	Apparent Maximal velocity	0	62	6
Organ distribution		0	61	61
Range of survival		0	61	53
Potency_Clk2_uM		0	61	1
Significance		0	61	5
KH		0	61	21
logMIC	log of MIC	0	61	21
Alpha E		0	61	5
KD/Ki		0	61	36
LBF	Liver blood flow	0	61	29
dP/dt20		0	61	2
Ratio_ATPase activity		0	60	1
SF		0	60	6
Chemotherapeutic index		0	60	3
Median day of death		0	60	54
Sensory evaluation		0	60	48
Potency_Dyrk1a_uM		0	60	1
% maximum response		0	60	1
Ratio LD50/EC50		0	60	2
Increase in CBF		0	60	6
Half duration		0	60	1
Virucidal		0	60	8
PCA shift		0	60	1
Baseline		0	60	18
MG MID		0	60	7
Free		0	60	21
DAR		0	60	56
Anticoccidial Activity		0	60	3
Erythroid induction		0	59	30
Relative hydrolysis		0	59	12
Arterial pressure		0	59	48
Mitotic index		0	59	22
T/C survival		0	59	56
Food intake		0	59	29
FSC		0	59	21
AE Score		0	59	2
Max PI		0	59	4
Other		0	59	9
UD50	ulcerogenic dose in 50% of the treated animals	0	59	38
RHT		0	59	3
ERP		0	59	23
Dose ratio		0	59	17
Relative salidiuretic activity		0	58	22
Inhibition concentration		0	58	11
Increase in dP/dt max		0	58	22
Zone of stimulation		0	58	17
Median survival day		0	58	54
Potency_Dyrk1b_uM		0	58	1
AWC		0	58	38
Neuroprotection		0	58	15
No. of entries		0	58	13
Tp control		0	58	20
KI_MICROM		0	58	1
MI50	Drug concentration causing 50% induction of mitotic index	0	58	11
IE50	Concentration required for 50% inhibitory effect	0	58	2
Reduction factor		0	58	6
Mean uterine weight		0	57	9
WBC		0	57	13
Survival increase		0	57	29
Inhibition index		0	57	3
Anti-pent effect		0	57	1
Protected mice		0	57	21
Total activity		0	57	10
Flu intensity		0	57	8
Reaction time		0	57	21
Response unit		0	57	5
NTP_AUC		0	57	14
Average		0	57	11
K aff		0	57	4
TC25		0	57	9
pA50		0	57	14
Surviving fraction		0	57	25
Max Achievable Bioavailability		0	56	7
pRA2		0	56	1
Phorbol displacement		0	56	2
Therapeutic index 99		0	56	2
Deuterium retention		0	56	25
Delta APD95 (max)		0	56	7
Log 10 cell kill		0	56	20
Median life span		0	56	48
Urinary volume		0	56	13
Modification		0	56	4
Responding		0	56	48
ZImax/KZI	Ratio of (maximum zone of inhibition) to (concentration required to reach half maximum zone of inhibition)	0	56	2
pTCD50	-log TCD50	0	56	24
pRA1		0	56	1
Lipid-soluble radioactivity		0	56	8
Maximal non-toxic dose 50		0	55	3
CAR		0	55	17
Removal of microfilariae		0	55	38
Platelet aggregation		0	55	10
Reactors/Test group		0	55	8
DOPA accumulation		0	55	10
Log 1/EDMES(2.5)		0	55	1
Saluretic score		0	55	10
Challenge time		0	55	4
NO formation		0	55	3
Log 10 LC50		0	55	55
EDMES(2.5)		0	55	1
CLtotal		0	55	33
Kd(app)	Apparent dissociation constant	0	55	12
rIC50		0	55	9
K Bind		0	55	4
Log AP		0	55	1
NOHA		0	55	5
ID75		0	55	3
TWI		0	55	45
PO2		0	55	14
pC		0	55	4
Serum total triglycerides		0	55	22
Mean arterial blood pressure change (average)		0	54	6
PFC		0	54	30
Receptor occupancy		0	54	9
Polyamine content		0	54	39
Analgesia duration		0	54	11
Apoptotic activity		0	54	5
Initial activity		0	54	2
Rotation number		0	54	9
log(10'6/IC50)		0	54	1
deltalog10CFU	delta log10 colony forming units	0	54	24
Maximal effect		0	54	5
Relative ID50		0	54	11
Log 1/LD50		0	54	3
Reactivity		0	54	11
Rel Max FI		0	54	2
Total dose		0	54	44
Delta APD90		0	54	19
Log D50		0	54	2
Rise HR		0	54	21
nHill		0	54	4
pKm	disscociation constant	0	54	7
No. of lung colonies		0	54	20
Punch weight/MPO activity		0	53	47
Anti-fighting behaviour		0	53	1
Min effective dose		0	53	7
Clined screen test		0	53	1
Behavioral effect		0	53	15
ED5	Effective concentration for 5% activity	0	53	19
Immobility time		0	53	13
Cells positive		0	53	39
CS index		0	53	2
Turns		0	53	30
Mean body weight		0	53	16
Rhodamine-123 accumulation		0	52	4
SER		0	52	21
Tissue concentration		0	52	28
Protective effect		0	52	28
Optical density		0	52	37
Reversal index		0	52	27
Cardiotoxicity		0	52	3
Eye toxicity		0	52	8
Stool output		0	52	37
-Log Kdiss		0	52	2
Non-HDL-C		0	52	35
Quantity		0	52	12
MFC99.9	Minimum fungicidal concentration for 99.9% activity	0	52	2
Delta p		0	52	6
GM-MIC		0	52	2
PTD50		0	52	5
VERP		0	52	30
EC95	Effective concentration for 95% activity	0	52	13
pKp		0	52	11
LMA		0	52	20
Fraction experiencing seizures		0	52	46
Relative inotropic potency		0	51	14
		0	51	41
cAMP activity index		0	51	2
packed cell volume		0	51	11
Activity of control		0	51	9
IC90 mutant/IC90 WT		0	51	4
Aneuploidy activty		0	51	2
Competition factor		0	51	6
mequiv of Na+/kg		0	51	5
Acceptor activity		0	51	1
ascites volume		0	51	8
Arthritic score		0	51	18
Cells treated		0	51	6
Lesion length		0	51	31
Growth Index		0	51	10
Growth rate		0	51	10
Total turns		0	51	11
Foci/dish		0	51	12
Log ESA		0	51	1
pIC90		0	51	1
Kiuc	Uncompetitive inhibition constant	0	51	21
Antihypertensive score		0	51	20
Flat body posture score (mean)		0	50	21
BDW		0	50	15
Beta-lactamase induction		0	50	7
Initial blood pressure		0	50	8
Rate of O2 consumption		0	50	50
GT fold stimulation		0	50	2
Modulation factor		0	50	4
Plasma clearance		0	50	30
Systemic effect		0	50	13
Total excretion		0	50	32
No effect dose		0	50	5
Efficacy ratio		0	50	2
Motor activity		0	50	31
FT mean score		0	50	20
Log 1/ratio		0	50	1
Virus yield		0	50	42
CTL activity		0	50	16
DNA binding		0	50	5
Avg IC90		0	50	2
Delta pH		0	50	4
Log K1		0	50	17
logCL	log of clearance	0	50	1
Days		0	50	24
AUEC	Area under effect curve	0	50	8
Antiarrhythmic activity		0	50	1
Survivors at day 30		0	49	22
IC	Inhibitory concentration	0	49	6
Control Uptake		0	49	1
Drug response		0	49	47
Reactivation		0	49	25
Delta TAO		0	49	4
T99.9%	Time to clear 99.9% of the initial inoculum	0	49	45
pEC100		0	49	2
Delta A		0	49	20
RIC50		0	49	5
Clast	Last measurable concentration	0	49	24
Vz/F		0	49	40
KD50		0	49	8
Ks/i		0	49	44
CC30	Cytotoxic concentration for 30% activity	0	49	12
ADI		0	49	1
BSI		0	49	4
N		0	49	37
FI		0	49	18
Transport rate		0	49	12
Relative inhibitory potency		0	48	8
CLb		0	48	8
Cytoprotective effect		0	48	3
Optimal concentration		0	48	3
No. protected/tested		0	48	10
Reversal scale value		0	48	23
Skin tests intensity		0	48	39
Broncho selectivity		0	48	2
log(solubility)		0	48	6
Plasma insulin		0	48	19
Behavior score		0	48	12
Efficacy index		0	48	19
Iron excretion		0	48	18
Cell survival		0	48	11
Contractility		0	48	13
Glucose rise		0	48	19
CT10 ratio		0	48	6
Irritation		0	48	6
GTP shift		0	48	6
Tm shift		0	48	10
log10FFU		0	48	48
P ABC		0	48	4
IA50		0	48	3
ID40		0	48	12
PWT		0	48	2
FI5	Drug concentration resulting in 5-fold increase in transcriptional activity compared to absence of the compound	0	48	2
RH		0	48	20
Increase in footpad thickness		0	48	33
Contragestational activity		0	47	6
Heart rate change (max)		0	47	6
Antihypertensive activity		0	47	6
Pgp AbA/analogue ratio		0	47	2
Antagonistic activity		0	47	17
Antimalarial activity		0	47	23
Rectal temperature		0	47	3
Compound remaining		0	47	11
[35S] TBPS shift		0	47	1
Insulin release		0	47	18
Response rate		0	47	26
Mean latency		0	47	20
Relative Ki		0	47	3
CBF Ratio		0	47	2
FBF Ratio		0	47	2
Mean IC50		0	47	6
Alphax10E		0	47	3
G Index		0	47	5
Log Ko		0	47	4
CFC20		0	47	4
Diastolic blood pressure change		0	46	12
LM		0	46	2
Average lesion score		0	46	17
Active/total cultures		0	46	43
Relative ET-A IC50		0	46	1
Tremorolytic dose		0	46	6
Variation/Control		0	46	27
Protected/tested		0	46	45
Relative uptake		0	46	2
Dose excreted		0	46	46
Relative rate		0	46	11
Log ILS max		0	46	3
Active dose		0	46	8
Competition		0	46	5
Log SOSIP		0	46	1
MDR ratio		0	46	3
Mydriasis		0	46	4
Log M50		0	46	2
Blockade		0	46	24
MED50		0	46	13
ED35	Effective dose for 35% activity	0	46	7
C175		0	46	1
PKa		0	46	10
REP		0	46	2
kr		0	46	21
Dissociation constant		0	46	5
No. of animals with liver necrosis		0	45	12
IOR		0	45	1
Apparent enzyme activity		0	45	1
Rate of hydrolysis		0	45	7
Possible response		0	45	8
Tubulin binding		0	45	2
cAMP production		0	45	9
Improvement		0	45	24
Relative F%		0	45	1
Relative Kd		0	45	2
log(1/CON)	log(1/partial pressure in atmosphere at which convulsion takes place)	0	45	1
logK(lung)		0	45	1
OD(540nm)		0	45	2
RAC app		0	45	5
LV FRP		0	45	27
ka/Ki		0	45	40
Alpha		0	45	7
pC60		0	45	4
kOH		0	45	4
Acute electroshock activity		0	45	4
Change in response rate		0	44	17
CPP		0	44	5
Plasma lipid level		0	44	24
Survivors at day 5		0	44	40
Administered dose		0	44	37
GSH-Px activity		0	44	2
AUC 0-infinity		0	44	8
Fraction cured		0	44	44
Reversal type		0	44	13
logK(blood)		0	44	1
Median T/C		0	44	39
Viscosity		0	44	11
pA2/pKB		0	44	2
Agonist		0	44	10
MTD50		0	44	5
CLint		0	44	9
Ki ss		0	44	1
EC75		0	44	3
Fabs	Fraction of the dose absorbed	0	44	18
LC30	Drug concentration causing 30% death of test organisms	0	44	6
LVP		0	44	5
Inhibition constant		0	44	1
Cytotoxic concentration		0	43	10
Ae		0	43	10
Inhibition over time		0	43	26
Tumor response		0	43	20
IC50 reduction		0	43	3
Potential		0	43	3
Unchanged		0	43	22
dP/dt max		0	43	6
P (Ei)		0	43	1
Influx		0	43	10
Kreact		0	43	7
Log Kw		0	43	5
ILS30		0	43	14
LT50	Mean time to kill 50 % of the test larvae	0	43	4
fAUC	Free Area under the concentration time curve	0	43	33
DR10		0	43	9
EPMR		0	43	6
Vdu	Unbound volume of distribution	0	43	1
CC10	Cytotoxic concentration for 10% activity	0	43	10
REA		0	43	4
LD5		0	43	1
RL		0	43	21
TP		0	43	5
pD		0	43	5
Deoxyribose degradation		0	43	3
NBT positive cells		0	42	21
Co		0	42	1
No. of shocks		0	42	20
Cell protein		0	42	36
Separation		0	42	1
Capacity		0	42	7
Csat/Co		0	42	1
APD60		0	42	12
Csat		0	42	1
PCY		0	42	1
RTW		0	42	31
Daq		0	42	1
k1		0	42	14
C24		0	42	4
K(p,uu,brain)		0	42	1
Weight change at nadir		0	41	18
PL		0	41	4
Ionotropic activity		0	41	9
Histamine release		0	41	11
DNA crosslinking		0	41	12
Migration index		0	41	31
Pigment binding		0	41	3
Max CF response		0	41	17
Max intensity		0	41	16
-Log IC25		0	41	3
LED100		0	41	11
MDD50		0	41	5
ED125		0	41	2
Log C		0	41	1
Fmut		0	41	12
MfI		0	41	3
RI		0	41	2
Body weight increase		0	41	5
Max inhibitory effect		0	40	16
MP		0	40	3
Activity in animals		0	40	13
Luciferase activity		0	40	3
Cytokine induction		0	40	4
Positive control		0	40	4
Aspirin formed		0	40	6
DNA relaxation		0	40	7
Log 1/ID75		0	40	1
Tumor size		0	40	14
Delta ERPc		0	40	2
Frequency		0	40	27
Kpot A,B		0	40	9
MES ED50		0	40	1
ED99.9		0	40	7
MTC50	minimum toxic concentration - causes 50% cell death	0	40	9
k2/Ki		0	40	7
EC12	Effective concentration for 12% activity	0	40	3
RPF		0	40	3
RTV		0	40	40
KSV	Stem-Volmer quenching constant	0	40	23
ASF		0	40	1
Mean no. of revertants		0	40	30
Temperature decrease (max)		0	39	6
RHA		0	39	3
Relative susceptibility		0	39	5
Infected mosquitoes		0	39	3
P24 concentration		0	39	11
Topical potency		0	39	2
Average dose		0	39	9
BCM serum Ca		0	39	4
Delta pCa50		0	39	11
IS/AAR		0	39	5
Kb app		0	39	2
TBMIC		0	39	1
Flea		0	39	1
I 90		0	39	13
TFS		0	39	28
D150		0	39	1
Rate of phosphorylation		0	39	3
Functional refractory period change (max)		0	38	5
C0	Initial plasma concentration	0	38	29
Residual contractile activity		0	38	3
Permeability coefficient		0	38	7
Histone_modification		0	38	12
PDH active/PDH total		0	38	4
Spontaneous activity		0	38	26
Vertebral blood flow		0	38	1
Lipid peroxidation		0	38	5
Partition ratio		0	38	27
Affinity ratio		0	38	6
Binding ratio		0	38	4
LogPapp	Log(Apparent permeability)	1	38	11
Log PR		0	38	3
GT rate		0	38	4
pKapp		0	38	3
% NO2-		0	38	3
Tox50		0	38	7
EC170		0	38	1
K aps		0	38	1
IC75	Inhibitory concentration for 75% activity	0	38	9
MLS		0	38	38
DAP		0	38	7
SD		0	38	2
BMF	Biomagnification factor	0	38	2
CIC		0	38	16
Relative luciferase response		0	38	14
Systolic blood pressure increase		0	37	23
BUN		0	37	23
30 day survival / total		0	37	21
Postsynaptic antagonist		0	37	2
Vasoconstriction effect		0	37	25
Dose-modifying factor		0	37	8
Hyperglycemic activity		0	37	11
Presynaptic antagonism		0	37	1
log(10'3/IC50)		0	37	1
A1 selectivity		0	37	1
Mu/kappa ratio		0	37	2
Delta max APD		0	37	6
P50e/P50c		0	37	1
Tension		0	37	1
Log Pm		0	37	2
PFU/ml	Plaque forming units per ml	0	37	11
TMED50	Threshold minimum 50% effective dose	0	37	8
fCmax	Free maximum concentration of drug	0	37	31
GMMIC		0	37	4
H ABC		0	37	2
RT50	Time required for 50% recovery of compound action potential	0	37	2
VT50	Vitality time 50%	0	37	2
Hmax		0	37	2
IT50	Time required to decrease 50% of compound action potential	0	37	2
L/CE		0	37	11
NSB		0	37	3
BNa		0	37	7
No. of animals exhibiting toxicity / Number of animals tested		0	37	37
Tubulin polymerization ratio		0	36	1
MA		0	36	9
Exp Inhib Constant		0	36	1
Incorporation rate		0	36	12
Intrinsic Toxicity		0	36	3
Plasma GH release		0	36	18
Ratio_brain/blood		0	36	9
Relative toxicity		0	36	10
Formation of NO2-		0	36	2
Relative binding		0	36	3
Reversal ability		0	36	6
Thymidine shift		0	36	2
Oxidation rate		0	36	8
Uptake at C50		0	36	5
nNOS activity		0	36	6
%Bound_Albumin		0	36	3
Ileal activity		0	36	6
Cross linking		0	36	6
Initial rates		0	36	3
Enzyme level		0	36	3
MIC50/MIC90		0	36	33
36Cl- uptake		0	36	1
Log 1/ED50		0	36	4
Delta/kappa		0	36	2
RBA ratio		0	36	3
Delta cpm		0	36	28
Delta pKi		0	36	16
Pressure		0	36	16
Beta t1/2		0	36	18
Log DSF		0	36	13
Log MIC		0	36	1
Kdiss	Dissociation rate constant	0	36	10
Log M		0	36	2
RC10		0	36	2
EC10		0	36	6
AI50		0	36	7
Amax		0	36	1
RVR		0	36	5
CMR		0	36	1
Rs		0	36	6
IG		0	36	6
Kq	Quenching constant	0	36	20
Degradation rate constant		0	36	7
Change from Control (LV dp/dt)		0	35	7
MF		0	35	5
Substrate specificity		0	35	4
Exhibiting turning		0	35	8
T-cell inhibition		0	35	5
Cellular reversion		0	35	3
Brain/Blood ratio		0	35	17
Ratio LD50/ED50		0	35	9
Control current		0	35	3
Seizure score		0	35	17
Eudismic ratio		0	35	14
Average turns		0	35	7
McPhail index		0	35	17
FSC recovery		0	35	2
Minimal dose		0	35	1
Log TCID50		0	35	5
p alphaKa		0	35	1
DNA damage		0	35	27
Log 1/ED40		0	35	2
Delta ERP		0	35	3
GSH level		0	35	4
-Log LC50		0	35	8
Others		0	35	29
pAlpha		0	35	1
Vss/F		0	35	33
IT100	Time required to decrease 100% of compound action potential	0	35	2
MPC4		0	35	2
MCD	Minimum curative dose	0	35	5
tR		0	35	6
Effective concentration		0	35	15
Rate of decomposition		0	34	6
CGI		0	34	7
Selectivity ratio S3/1		0	34	2
Phosphorylation rate		0	34	2
Cell cycle analysis		0	34	7
Rolipram activity		0	34	3
Cardio selectivity		0	34	6
Cells in metaphase		0	34	20
Jump latency time		0	34	12
Max hypotension		0	34	4
Parent compound		0	34	4
No. of retches		0	34	33
LDL cholesterol		0	34	14
PI metabolism		0	34	2
Kill at C50		0	34	4
Caco-2 Papp		0	34	2
Delta Gsolv		0	34	1
Activity A		0	34	2
Delta Fmax		0	34	5
HVA level		0	34	14
SH level		0	34	6
Log KAT		0	34	1
Currents		0	34	4
ED Arec		0	34	9
Km(app)	Apparent Km	0	34	6
Ki low		0	34	29
E 1/2		0	34	2
rf50		0	34	4
EC37		0	34	5
TAR		0	34	2
Bapp		0	34	5
CTS		0	34	1
GSH		0	34	13
KOX		0	34	2
k0		0	34	16
Range of survival days		0	34	34
Phospholipidosis as % of positive control		0	33	1
KT		0	33	1
No. positive cases/tested		0	33	15
Relative inhibition index		0	33	2
Selectivity coefficient		0	33	3
Accumulation coefficient		0	33	23
inhibition of control		0	33	4
Cytokinetic response		0	33	8
Functional profile		0	33	10
Inotropic effect		0	33	5
Stereotypy score		0	33	13
Specific index		0	33	2
No of monkeys		0	33	21
Change of CF		0	33	7
Change of CO		0	33	7
Change of HR		0	33	7
Log Doct/PBS		0	33	3
cGMP content		0	33	6
HVA control		0	33	27
Total score		0	33	11
Tumor free		0	33	6
AE activity		0	33	6
Catalepsy		0	33	18
Max dose		0	33	7
Symptoms		0	33	8
-Log 1/Kb		0	33	1
T/C min		0	33	16
MI100		0	33	6
EC10x		0	33	3
GID75	Inhibition dose causing 75% growth inhibition	0	33	7
SSAT		0	33	4
aPTT		0	33	5
E1/2		0	33	3
CD90	90% Curative dose	0	33	6
EC2	Effective concentration for 2% activity	0	33	5
ISC		0	33	24
ki		0	33	17
IM		0	33	22
IW		0	33	22
Maximum test concentration that did not exhibit cytotoxicity		0	33	1
Reverse transcriptase activity		0	32	16
CQ	Drug concentration required to quadruple induction	0	32	1
Average No. of metastasis		0	32	14
DNA photo-crosslinking		0	32	3
Volume distribution		0	32	21
Cytostatic activity		0	32	6
Hepatic cholesterol		0	32	20
Scavenging activity		0	32	3
No. of circlings		0	32	4
No. of platelets		0	32	3
Ratio LD50/IC50		0	32	1
Animals positive		0	32	22
Activation time		0	32	2
PTZ seizure		0	32	2
Log 1/IC50		0	32	2
Repression		0	32	2
DA response		0	32	5
Dry weight		0	32	4
Plasma GH		0	32	13
Log D6.8		0	32	1
RLU/well		0	32	4
Log B/F		0	32	5
EC0.01		0	32	2
MLD50		0	32	2
pGC50	-log of GC50 (Concentration for 50% reduction of cell viability)	0	32	1
Basal		0	32	6
CIC95	cell culture 95% inhibitory concentration	0	32	10
RBA1		0	32	1
RBA2		0	32	1
EC40		0	32	17
pkB		0	32	4
MRF		0	32	1
Cl-		0	32	29
Transcriptional activation		0	32	11
No. of nonpregnant/treated		0	31	20
MI		0	31	4
Binding site preference		0	31	2
Binding stoichiometry		0	31	1
Antilipid peroxidation		0	31	6
DHP-I susceptibility		0	31	2
Max collateral index		0	31	2
Change from control		0	31	2
Max possible effect		0	31	21
Packed cell volume		0	31	4
Survivors at day 9		0	31	6
Tail flick latency		0	31	18
Tail vein toxicity		0	31	7
Uterine wet weight		0	31	14
Rate of formation		0	31	10
Treatment period		0	31	5
Decrease in Bmax		0	31	7
Time above IC50		0	31	11
Collateral index		0	31	2
Urinary output		0	31	6
-log(RatioIC50)		0	31	1
Ca2+ transport		0	31	11
SOD activity		0	31	3
-Log activity		0	31	1
Relative PT		0	31	1
MIC+/MIC-		0	31	2
NG ratio		0	31	2
Delta FC		0	31	1
pEC0.5		0	31	2
EC0.25		0	31	2
EC1000	Effective concentration for 1000% activity	0	31	5
pEC15		0	31	1
pC25		0	31	3
FL-1		0	31	4
SSC		0	31	4
Crel		0	31	10
MUD		0	31	16
Vc	Apparent volume of the central or plasma or serum compartment	0	31	13
Fluorescence activity ratio		0	31	4
Dissociation rate constant		0	30	12
KF		0	30	7
Electrolyte excretion		0	30	11
Concentration in serum		0	30	6
Mean time to seizure		0	30	30
ID (per g of organ)		0	30	30
Inhibition (basal)		0	30	1
Mean no. of shocks		0	30	7
Residual secretion		0	30	1
Serum triglyceride		0	30	8
Speed of induction		0	30	3
Phototoxic effect		0	30	2
Average peak Concn		0	30	4
DLS Concentration		0	30	2
Mean day of death		0	30	28
Log sweet/bitter		0	30	4
Range of deaths		0	30	25
Ratio LC50/IC50		0	30	7
PTZ protection		0	30	1
Worm reduction		0	30	10
Skin reaction		0	30	26
A2 selectivity		0	30	4
NADH oxidation		0	30	12
Cardiac force		0	30	2
Differential		0	30	2
Cell cycle		0	30	30
Immobility		0	30	21
Least dose		0	30	3
Kcat(app)		0	30	3	BAO_0000481 (kcat)
Velocity		0	30	2
Log CFU		0	30	2
Assembly		0	30	3
-Log Kd		0	30	6
-Log K		0	30	12
E/Emax	Efficacy/maximum efficacy	0	30	2
Log KA		0	30	1
T inh		0	30	4
T/C 1		0	30	23
In/Fi		0	30	24
K rel		0	30	2
MSIC		0	30	20
2x PT		0	30	8
IC2x		0	30	5
T/V		0	30	4
VAR		0	30	2
k2'		0	30	8
KD'		0	30	12
k3		0	30	9
GM		0	30	11
No. of cultures active/total		0	30	28
Mean enhancement of binding		0	29	15
Kn		0	29	3
Top1 cleavage activity		0	29	16
Antibody stimulation		0	29	22
Max tolerated dose		0	29	9
Activity remaining		0	29	13
Blood flow change		0	29	9
Drug uptake(free)		0	29	8
Feed consumption		0	29	1
Maximal efficacy		0	29	1
Max contraction		0	29	3
Optimal dosage		0	29	2
Feed efficiency		0	29	1
Toxicity zone		0	29	4
Coronary flow		0	29	4
No. of errors		0	29	14
Heart weight		0	29	10
Net log kill		0	29	25
VDR affinity		0	29	4
log10 TCID50	log (Tissue culture infective dose 50)	0	29	17
MPO release		0	29	2
Total cells		0	29	17
New tumors		0	29	23
PGE2 Level		0	29	3
Reversible		0	29	5
Acid output		0	29	28
pKi ratio		0	29	6
ED ratio		0	29	4
log10cfu	log10 colony forming units	0	29	17
-Log K0.5		0	29	1
Delta mV		0	29	6
log1/S		0	29	1
pLADY		0	29	2
Occ90	90% receptor occupancy in brain	0	29	16
EC>90	Effective concentration for >90 % activity	0	29	1
Nr/N		0	29	23
pC3		0	29	1
CLIP		0	29	1
NCC		0	29	1
RHR		0	29	5
CTE		0	29	8
RM		0	29	8
RV		0	29	1
BFU		0	29	27
Respiratory frequency		0	29	21
Mean log concentration ratio		0	28	9
Vm		0	28	9
Anti-uterotrophic effect		0	28	5
Inverse relative potency		0	28	3
Lowest effective dose		0	28	3
Binding competition		0	28	5
Organ weight ratio		0	28	2
Analgesic response		0	28	24
VCR accumulation		0	28	4
Arrhythmias times		0	28	12
Covalent binding		0	28	8
Ratio GI50/EC50		0	28	4
Saline control		0	28	18
Tumors with CR		0	28	28
Agonist potency		0	28	12
Antiviral index		0	28	3
Cellular uptake		0	28	5
Effectiveness		0	28	6
Gated current		0	28	5
A-selectivity		0	28	1
No. of rats		0	28	6
P50e / P50c		0	28	1
Brain uptake		0	28	15
LogK-IAMex		0	28	2
Relativity		0	28	9
Adjusted Ki		0	28	1
Edema ratio		0	28	4
Grip score		0	28	2
Cat score		0	28	2
Delta P50		0	28	1
Content		0	28	4
pKred		0	28	1
pLADM		0	28	1
MIC70	Minimum inhibitory concentration in 70% of population	1	28	1
CPE50		0	28	5
n50e		0	28	1
APD50		0	28	17
AERP		0	28	20
Glyburide reversibility		0	28	3
Animals responding / animals tested		0	27	27
Kt		0	27	15
Amount of cross-linked protein		0	27	3
Min lytic concentration		0	27	2
Muscarinic agonist index		0	27	1
Myoblasts with parasites		0	27	22
Volume of ascrit fluid		0	27	2
Cells differentiated		0	27	6
ID (per g of tissue)		0	27	19
Long-term survivors		0	27	19
Reversibility ratio		0	27	1
Survivors at day 10		0	27	6
Plasma selectivity		0	27	2
GTP-gammaS index		0	27	3
Monoamine level		0	27	9
No. of pos rxns		0	27	5
AdoMetDC levels		0	27	1
Apoptosis index		0	27	14
Min oral dose		0	27	6
Tumor uptake		0	27	2
pKi1-pKi2		0	27	1
Occupancy		0	27	9
Log Kobs		0	27	1
Delta IC		0	27	14
ascrit		0	27	2
p nMED		0	27	1
FRP C20		0	27	2
Log K2		0	27	6
SC200		0	27	3
T-C/C		0	27	25
dp/dt		0	27	27
NOEC		0	27	9
SD50		0	27	5
ID16		0	27	2
ID84		0	27	2
pCF		0	27	1
pNF		0	27	1
MCT		0	27	11
ODC		0	27	1
PD2		0	27	15
CPM		0	27	8
VF		0	27	11
kn		0	27	2
Modification of hemoglobin		0	27	12
Alpha-adrenolytic activity		0	26	3
Ko		0	26	4
Lowest effective concentration		0	26	2
No. of escape failures		0	26	14
Natriuretic activity		0	26	5
Speed of performance		0	26	14
Antibiotic resistance		0	26	9
Binding selectivity		0	26	8
Kaliuretic activity		0	26	5
Intrinsic efficacy		0	26	7
Lactone production		0	26	26
Staining potential		0	26	26
Substrate activity		0	26	7
Unaltered compound		0	26	2
Urinary excretion		0	26	26
Ventricular rate		0	26	23
Alpha-cholesterol		0	26	4
Residual peptide		0	26	6
Serum Mg2+ level		0	26	9
Surviving factor		0	26	11
Potency_Clk3_uM		0	26	1
Ca2+ antagonism		0	26	2
Cleavage rate		0	26	4
Pleural fluid		0	26	5
Etopic beats		0	26	23
Plaque accum		0	26	26
Sinus beats		0	26	8
tox/total		0	26	24
Log beta3		0	26	3
logEC50		0	26	5
2 x APTT		0	26	5
C20 FRP		0	26	14
PC100		0	26	1
Sp St		0	26	1
pAI50		0	26	2
EC125		0	26	1
RD50		0	26	1
ID80		0	26	1
AP50		0	26	3
CCCT		0	26	7
R.I		0	26	2
RCI		0	26	9
ICD		0	26	1
Kif		0	26	11
Tp		0	26	3
Tt		0	26	2
B		0	26	10
Day of first positive reaction		0	26	3
Rate of alkylation of NBP		0	25	3
CV		0	25	19
No. resp animals / Total		0	25	25
Relative enzyme activity		0	25	1
Biological evaluation		0	25	5
Relative tumor growth		0	25	1
Mean graph mid point		0	25	1
Uptake/Binding ratio		0	25	1
Mean life extension		0	25	12
Excess zone radius		0	25	10
Binding inhibition		0	25	8
Epileptogenicity		0	25	4
Relative maximum		0	25	5
Actual duraction		0	25	17
Calcium release		0	25	2
Cumulative dose		0	25	9
T/C untreated		0	25	1
Change in WBC		0	25	2
Phototoxicity		0	25	8
Rate response		0	25	25
Max lowering		0	25	6
Total tumors		0	25	13
AlDH activity		0	25	8
AH interval		0	25	12
E2 response		0	25	1
P50d/P50c		0	25	6
Passivity		0	25	3
Erythema		0	25	23
Log AC50		0	25	5
Log K-1		0	25	11
Reflex		0	25	3
EC1.5	Drug level causing 1.5 fold enhancement of enzyme activity	0	25	1
ICmax	Maximal inhibitory concentration	0	25	4
CS50	50% cytostatic concentration	0	25	4
Occ	Receptor occupancy	0	25	3
HSF		0	25	2
Kd1		0	25	8
Brain penetration index		0	25	17
Delta C urate / delta C insulin		0	24	10
LD	Lethal dose	0	24	14
Antiinflammatory Activity		0	24	3
Biodistribution ratio		0	24	24
Formation of erythema		0	24	9
No. of mice recovered		0	24	24
Ref I oncostatic index		0	24	14
Selectivity ratio S3/2		0	24	2
% nucleotide present		0	24	11
Aggregation response		0	24	23
No. of axonal points		0	24	3
Precursor inhibition		0	24	12
Transport inhibition		0	24	6
No. toxicity/tested		0	24	4
Femoral blood flow		0	24	2
Suppression ratio		0	24	3
Astrocyte reversal		0	24	24
Cardiac depression		0	24	1
Delta latency time		0	24	2
Time constant T1		0	24	4
Time constant T2		0	24	4
Enzyme inhibition		0	24	2
Mean no. colonies		0	24	14
Net accumulation		0	24	3
Oncostatic index		0	24	19
Reduction in RBS		0	24	3
NADPH oxidation		0	24	5
Tritium release		0	24	5
Verapamil index		0	24	3
Total binding		0	24	13
Lysis diameter		0	24	4
ODC activity		0	24	10
Water intake		0	24	7
HSF release		0	24	4
Ca2+ current		0	24	7
Cage leaving		0	24	11
Mean score		0	24	11
pA2 - pA10		0	24	2
IC50/[E]		0	24	3
Log TA98		0	24	2
Rate max		0	24	12
Beats/min		0	24	19
Rel max		0	24	1
log1/S0		0	24	1
EC50 iGC		0	24	1
MG-MID		0	24	2
T/C 41		0	24	1
T/C-CQ		0	24	1
pKact		0	24	11
Delyse		0	24	4
Log D5		0	24	3
RC50	Concentration required for 50% reduction of control absorbance	0	24	2
kOH-		0	24	1
ED75	Effective dose for 75% activity	0	24	4
Emin		0	24	2
apE		0	24	1
ClT		0	24	6
K'a		0	24	2
pH		0	24	12
BWL		0	24	24
Urinary glucose excretion		0	24	1
Mean hemagglutination titers		0	23	20
PG		0	23	5
Flat body posture score		0	23	6
Plasma-E2 concentration		0	23	14
Tubulin polymerization		0	23	3
Anesthesia duration		0	23	3
Effective molarity		0	23	4
[Ca2+] variation		0	23	10
Caspase induction		0	23	1
Max IOP reduction		0	23	3
Delta Vmax (max)		0	23	8
Dopamine release		0	23	1
No. of transfers		0	23	9
Volume increase		0	23	6
No. of crosses		0	23	14
Phosphorolysis		0	23	2
DHP-I stability		0	23	2
Spleen weight		0	23	20
Dose interval		0	23	2
Mean log GI50		0	23	9
QTc interval		0	23	4
pEC0.5,diss		0	23	4
Log10 ED50		0	23	3
Tumor cure		0	23	12
Change MAP		0	23	4
ED delta20		0	23	2
ED delta5		0	23	2
Emax,diss		0	23	4
Influx Ki		0	23	10
Delta RM		0	23	1
Palpha		0	23	4
CL(app)	Apparent clearance	0	23	1
CLT50		0	23	2
MFED		0	23	5
pC2A		0	23	1
Kact	Concentration of compound(agonist) required for half maximal activity	0	23	6
TOX		0	23	10
AC10		0	23	6
PMA		0	23	2
RBI		0	23	2
S.I		0	23	4
ED6		0	23	2
FPT		0	23	5
Kd2		0	23	9
ST		0	23	10
A	Radial growth inhibition of a microbial colony	0	23	13
Hydrogen peroxide degradation		0	23	1
Minimal bacteriostatic concentration		0	22	8
Ca2+		0	22	8
TGI correlation coefficient		0	22	1
Concentration_unbound_plasma		0	22	17
Physical dependence capacity		0	22	9
Change in entry latency		0	22	2
Mean activity counts		0	22	21
Heart rate decrease		0	22	13
Intestinal toxicity		0	22	3
Paw weight increase		0	22	1
Log 1/D125 (L1210)		0	22	1
Mean vesicle score		0	22	19
Agonistic activity		0	22	8
Cytocidal activity		0	22	9
Thymidine uptake		0	22	22
Time constant T3		0	22	3
Edema inhibition		0	22	1
Gastric toxicity		0	22	2
Observed log APA		0	22	1
PDE inhibition		0	22	2
Tissue levels		0	22	11
Duration time		0	22	17
HV interval		0	22	14
Log potency		0	22	1
Ulcer index		0	22	15
Ulcer score		0	22	6
Log 1/conc		0	22	1
Funbound		0	22	9
Ke ratio		0	22	10
TOC ED50		0	22	11
Log APA		0	22	1
X1(50)		0	22	2
BW loss		0	22	19
CV dose		0	22	1
Occ50	50% receptor occupancy in brain	0	22	6
TGI50		0	22	8
logSI	log (Selectivity Index)	0	22	2
E max		0	22	4
IC>80		0	22	2
Vrel		0	22	2
nAUC		0	22	14
Eggs		0	22	2
Gain		0	22	6
c30		0	22	1
c90		0	22	1
C100		0	22	2
Increase in plasma amylase		0	22	10
Postjunctional agonist potency		0	21	1
BT		0	21	16
Postjunctional antagonist potency		0	21	2
Picoequivalents of amine/10e6 cells		0	21	1
Final average tumor weight		0	21	21
Absolute turn angular/3 min		0	21	3
Initial average tumor weight		0	21	21
Prejunctional agonist potency		0	21	1
Serum lipoprotein cholesterol		0	21	21
Mean number of parasites		0	21	17
Incidence of RBC decrease		0	21	8
Symptom initiation		0	21	7
Swimming activity		0	21	12
Log delta (1/T2)		0	21	1
Pressor activity		0	21	4
Retention ratio		0	21	1
Thrombus weight		0	21	10
AI recovery time		0	21	12
Change non HDL-C		0	21	9
Testes weight		0	21	20
Change HDL -C		0	21	9
Creatinine_CL		0	21	12
No. effective		0	21	15
Potency index		0	21	2
QT interval		0	21	19
Total lysis		0	21	13
Log K' IAM		0	21	1
Wet weight		0	21	9
Delta pEC50		0	21	1
AUC 0-tldc		0	21	1
Creatinine		0	21	12
Hill slope		0	21	3
Log 1/D125		0	21	2
Log TA100		0	21	2
LH level		0	21	21
Log CC50		0	21	1
Relapses		0	21	11
Log MBC		0	21	1
Treated		0	21	18
logC50	log of C50	0	21	1
-Log KA		0	21	1
Cmax/SS		0	21	2
K calc		0	21	1
Log K3		0	21	4
d tox		0	21	1
fCmin	Free minimum drug concentration	0	21	21
GII50		0	21	1
HD100	Dose required for 100% hemolysis	0	21	2
Kbapp	Apparent dissociation constant	0	21	5
Tlag	Lag time between drug administration and first detectable serum concentration	0	21	11
K1/2	Concentration required for Half-maximal effect	0	21	2
TGD		0	21	17
NEA		0	21	2
POT		0	21	1
HTD		0	21	1
KDs		0	21	11
Prejunctional antagonist potency		0	21	2
ID99		0	20	5
NSR		0	20	11
CTF		0	20	2
ED3		0	20	4
I/C		0	20	1
K50		0	20	1
Pw		0	20	16
C8h		0	20	1
DP		0	20	1
Ip		0	20	16
No. of mice effected/No. of treated		0	20	11
Recovered radioactivity		0	20	20
Serum HDL-cholesterol		0	20	11
Serum LDL-cholesterol		0	20	11
Fluorescence intensity		0	20	4
Degree of resistance		0	20	2
Mortality inhibition		0	20	1
Concentration ratio		0	20	7
Epidermal thickness		0	20	17
Heart rate increase		0	20	7
Highest active dose		0	20	19
Hemodynamic change		0	20	20
Plasma cholesterol		0	20	18
Survivors at day 8		0	20	10
Triglyceride level		0	20	13
Tumor growth delay		0	20	12
Ca2+ transport S/M		0	20	2
Cytotoxic endpoint		0	20	3
Turns/first hour		0	20	1
Cardiac frequency		0	20	20
Complex_formation		0	20	14
Enhancement ratio		0	20	5
No. of writhings		0	20	9
Residual binding		0	20	1
increase in RFU		0	20	1
Decrease in RFU		0	20	1
Change in cAMP		0	20	1
DNA alkylation		0	20	5
FPG correction		0	20	7
Nephrotoxicity		0	20	16
Catalase rate		0	20	1
Lipophilicity		0	20	5
PI hydrolysis		0	20	1
Prolongation		0	20	14
Total counts		0	20	20
Average onset		0	20	19
Log K delta		0	20	2
Urinary Na+		0	20	20
TBPS IC50		0	20	1
2DG uptake		0	20	5
Cmax/dose		0	20	9
Flow rate		0	20	12
ED (1mV)		0	20	1
Log II50		0	20	4
Mean LAF		0	20	5
Mean RBF		0	20	5
p[BH+50]		0	20	1
-Log EC20		0	20	2
Mean HR		0	20	5
Removal		0	20	6
AUC 0-6h		0	20	3
MAPD90		0	20	1
pID50		0	20	1
pLADm		0	20	2
BHIA50		0	20	2
Emesis		0	20	14
Intact		0	20	4
APD90		0	20	14
Log Y		0	20	3
Mice		0	20	4
k2''		0	20	6
-ln K		0	20	1
IC60	Inhibitory concentration for 60% activity	0	20	8
ID95	Drug concentration causing 95% inhibitory activity	0	20	3
[EOP']infinity/[EOH]infinity		0	19	19
K6		0	19	3
Survivors at day 15		0	19	10
Lethal dose (approx)		0	19	1
Average seizure score		0	19	16
Blood urea nitrogen		0	19	8
Horizontal activity		0	19	13
Selectivitiy factor		0	19	1
No. of metastases		0	19	6
Time constant T4		0	19	3
Urine osmolality		0	19	11
Antagonist effect		0	19	12
Combination_index		0	19	15
Duration of block		0	19	16
Na+ ion content		0	19	15
Ca2+ elevation		0	19	5
Infarct volume		0	19	13
K+ Ion content		0	19	15
Max hemorrhage		0	19	6
Cation influx		0	19	5
K+/Na+ ratio		0	19	2
Tumor growth		0	19	12
Skin uptake		0	19	1
% remaining		0	19	2
1/kobsd-ka		0	19	19
Cmax_[GH]		0	19	4
IC50/IC50		0	19	2
Liver TG		0	19	12
Log CDGH		0	19	1
Log CDQR		0	19	1
log KOA	Octanol-air partition coefficient	0	19	1
Ki high		0	19	17
pKinc		0	19	1
pLADy		0	19	1
K diss		0	19	5
MED90		0	19	3
MlogP		0	19	1
MNTC		0	19	4
ERP1		0	19	1
ERP3		0	19	1
TVI		0	19	18
ABBC	Area between control growth and time kill curves	0	19	19
AUMC	Area under the first moment curve	0	19	11
Corr		0	19	9
PFU		0	19	13
PKC		0	19	3
CT1		0	19	1
CT2		0	19	1
FOC		0	19	1
ke		0	19	1
Max aggregation response		0	19	15
Parasites		0	18	18
Log LD50		0	18	2
Log Pc18		0	18	1
A/B ratio		0	18	2
Stomach		0	18	1
CE logK'		0	18	1
Nature		0	18	10
Km/Kcat		0	18	3
KD app		0	18	2
[GSH]		0	18	4
GHmax		0	18	1
K eff		0	18	4
Q1/2		0	18	1
krel		0	18	3
pK1a		0	18	1
pK1b		0	18	1
pK1d		0	18	1
Dmax		0	18	2
G2/M		0	18	11
CE37		0	18	1
MRP		0	18	3
MTS		0	18	1
N/A		0	18	4
Q50	Concentration required for 50% quenching of fluorescence	0	18	1
CT3		0	18	2
CT5		0	18	1
FBF		0	18	3
GOF		0	18	2
QT		0	18	12
kR		0	18	3
DT		0	18	2
IE		0	18	4
K'		0	18	3
Mean day appearance of lesions		0	18	9
Mean arterial blood pressure decrease (max)		0	18	11
Mean no. of lung colonies		0	18	6
Min antiviral concentration		0	18	12
Muscarinic receptor affinity		0	18	2
Macrophage cytotoxicity		0	18	3
Differential affinity		0	18	1
Uterotrophic activity		0	18	4
No. of lung metastasis		0	18	18
Relative molar potency		0	18	9
Serum corticosterone		0	18	17
Anticonvulsant dose		0	18	3
Antiemetic activity		0	18	1
Relative ODN uptake		0	18	2
Dissociation ratio		0	18	1
Glucose correction		0	18	5
Hemolytic activity		0	18	1
Initial rate ratio		0	18	1
Metabolic turnover		0	18	1
Selective toxicity		0	18	1
Partial remission		0	18	11
Prodrug reduction		0	18	11
Change in conflict		0	18	4
Chemotactic index		0	18	8
Hypnosis duration		0	18	12
Insulin secretion		0	18	1
Colony formation		0	18	12
Control response		0	18	15
ERP observations		0	18	7
Extremes treated		0	18	6
Gastric emptying		0	18	1
Med tumor weight		0	18	18
Rate of decrease		0	18	12
Succeeded/tested		0	18	3
Survival treated		0	18	6
Onset of action		0	18	4
Polyamine pools		0	18	9
Adduct formation		0	18	2
Remaining rate		0	18	2
Thyroid status		0	18	9
Conversion dose		0	18	16
Histamine level		0	18	13
Cured/Infected		0	18	16
MTX equivalent		0	18	12
Net dry weight		0	18	2
Fold_activity		0	18	1
Cmax_unbound		0	18	15
Initial_rate		0	18	12
Phagocytosis		0	18	1
Slow binding		0	18	8
Thymolysis		0	18	4
Acc. counts		0	18	4
Average AUC		0	18	2
Binding max		0	18	10
TGI ratio		0	18	2
Uncut DNA		0	18	3
Activity B		0	18	3
Difference		0	18	3
GI50 ratio		0	18	2
LC50 ratio		0	18	2
Cell size		0	18	6
Delta F75		0	18	3
GI50/EC50		0	18	3
Imbalance		0	18	2
Relative daunomycin accumulation		0	17	1
KR	Dissociation constant at resting state	0	17	7
Accumulated counts/30 min		0	17	13
DNA cleavage activity		0	17	1
Thromboxane B2 (TxB2)		0	17	3
Antipapilloma activity		0	17	5
Relative lipophilicity		0	17	2
G-protein activation		0	17	1
Hydrophobicity index		0	17	1
Caco-2 permeability		0	17	12
Pigment induction		0	17	2
Iron mobilization		0	17	4
Mean response/min		0	17	13
Tonic seizures		0	17	17
Vmax / Kmax100		0	17	3
Agonist Potency		0	17	3
DNA replication		0	17	2
Aberrant cells		0	17	16
Metabolic rate		0	17	7
LDL oxidation		0	17	5
GABA current		0	17	5
Rats blocked		0	17	4
Synergy EC50		0	17	1
Tumor burden		0	17	11
Average score		0	17	10
LDH release		0	17	6
TC lowering		0	17	14
Log Pe,max		0	17	2
Sterilized		0	17	1
Time spent		0	17	2
ToxD/Surv		0	17	8
efflux_CL		0	17	17
influx_CL		0	17	17
C cellular		0	17	7
Cr release		0	17	14
Day 22-T/C		0	17	3
Day 9-RTV		0	17	4
Mean IC70		0	17	2
P2 uptake		0	17	2
ElogDoct		0	17	2
Max cAMP		0	17	2
Log Po		0	17	2
Cp max		0	17	4
FS-SIF		0	17	2
Vbeta	Terminal Phase Vdss	0	17	9
clogD		0	17	1
AUC T		0	17	7
Load		0	17	8
Fapp	Apparent oral bioavailability	0	17	6
k-2		0	17	2
MDR		0	17	6
PEI		0	17	3
E50		0	17	2
Keq		0	17	5
ABC		0	17	6
S		0	17	12
AD		0	17	2
EA		0	17	1
FE		0	17	7
Fraction of accumulated 86Rb remaining.		0	17	9
Unbound		0	16	3
Alpha Ki		0	16	7
Delta Gm		0	16	1
Normal		0	16	11
-Log Kb		0	16	4
AUC inf		0	16	8
EC50rel		0	16	4
Infarct		0	16	15
E/Eref		0	16	2
ED2sec		0	16	1
ER max		0	16	1
Log DC		0	16	4
Log KH		0	16	2
Log KL		0	16	3
MED10		0	16	2
NOAEL	No observable adverse effect level	0	16	14
Urine		0	16	6
Varea		0	16	3
logKd		0	16	2
D7.4		0	16	1
FC50		0	16	2
HT50		0	16	16
KiAH		0	16	3
VSS		0	16	2
pK3		0	16	5
RTP		0	16	2
ILB		0	16	4
BMD		0	16	4
A0		0	16	3
Relative esterase susceptibility		0	16	3
Cell protein in untreated control		0	16	11
Mean arterial pressure change (average)		0	16	16
Decrease in the QA interval		0	16	8
Heart rate change (average)		0	16	16
Relative intrinsic activity		0	16	1
Time to max. inhibition		0	16	6
Radioactive constituents		0	16	16
Reduction in virus titer		0	16	14
Relative Bioavailability		0	16	5
Effect on polyamine pools		0	16	2
Gastric concentration		0	16	5
Reduction in movement		0	16	4
Specific Displacement		0	16	4
Amount of Acotine used		0	16	8
Inhibition of damage		0	16	3
Concentration_blood		0	16	14
Resistance reversal		0	16	9
Maximal relaxation		0	16	1
Mutation frequency		0	16	8
Original amplitude		0	16	2
Tissue/Blood ratio		0	16	16
Rate of reduction		0	16	3
Acute tolerability		0	16	11
Tensile strength		0	16	1
Ulcerative index		0	16	4
Inactivation time		0	16	11
Inotropic potency		0	16	4
Serum metabolite		0	16	1
Suppressive dose		0	16	1
Remaining ratio		0	16	1
Amount delivered		0	16	4
Relative value		0	16	1
Incidence_count		0	16	16
Ca2+ reduction		0	16	2
Funbound_blood		0	16	6
Funbound_serum		0	16	11
Hematotoxicity		0	16	2
Control value		0	16	5
MTT reduction		0	16	4
No. of canine		0	16	16
Colony_count		0	16	10
Tidal volume		0	16	8
Probability		0	16	2
CTS increase		0	16	1
Carbohydrate		0	16	7
AUC_aspirin		0	16	1
CT-luci TAR		0	16	1
Conc_plasma		0	16	10
Stretches		0	16	8
Delta IC50		0	16	2
Dependency		0	16	10
Dose range		0	16	7
Fungicidal		0	16	7
Ionization		0	16	2
CC50/EC50		0	16	1
No. total		0	16	8
EC90/MIC		0	16	6
ECAUC0.2		0	16	2
HF ratio		0	16	2
Inflamed		0	16	12
Log t1/2		0	16	2
Negation		0	16	14
AUC 0-24h		0	16	11
CMax		0	15	4
RMP		0	15	12
K-1		0	15	8
APA		0	15	9
B50		0	15	2
CR		0	15	11
Relative differentiating activity		0	15	3
Insulin-sensitizing activity		0	15	1
Mineral apposition rate		0	15	15
Total number of entries		0	15	1
Triglyceride correction		0	15	3
Antiuterotrophic activity		0	15	3
Hemispheres reduction		0	15	8
No. of suncus vomited		0	15	10
Extent of skin lesions		0	15	15
Plasma protein binding		0	15	7
3H-TdR incorpolation		0	15	3
Decrease in fighting		0	15	3
Max agonist response		0	15	9
Alkylating activity		0	15	3
Blood glucose level		0	15	5
Communicating cells		0	15	5
GTP-gamma35S bound		0	15	2
Remaining compound		0	15	3
Resting potential		0	15	8
Vasodilatory rate		0	15	9
-Log concentration		0	15	1
Cell proliferation		0	15	6
Inhibitory effect		0	15	9
Log concentration		0	15	13
Plasma half-life		0	15	5
Preventive index		0	15	1
Max fall in IOP		0	15	4
PLC Stimulation		0	15	1
Max protection		0	15	7
NBT positivity		0	15	6
Decrease RVR		0	15	1
Fresh weight		0	15	6
Log 1/Th+200		0	15	1
Log 1/B+100		0	15	1
Amount bound		0	15	1
Cells living		0	15	9
pEC50 diss		0	15	5
Delta HDL-C		0	15	12
kinact/Ki		0	15	3
Alkylation		0	15	3
Ca2+ flux		0	15	6
Log 1/B+1		0	15	2
Log 1/B.5		0	15	2
Hx shift		0	15	1
Lag time		0	15	2
RVR ED15		0	15	1
Log K'W		0	15	1
T/C 1.2		0	15	12
WLC PRA		0	15	2
log KOW	Octanol-water partition coefficient	0	15	3
p alpha		0	15	5
p10 MIC		0	15	4
t1/2eff	Effective half life	0	15	1
-Log I50		0	15	1
CLogD7.4	Calculated Log(Distribution Coefficient) at pH7.4	1	15	1
Vm/Km		0	15	3
Log2		0	15	4
DC50	concentration required for a 50% reduction of cell viability	0	15	5
HC30	Concentration required for 30% hemolysis	0	15	1
VCT		0	15	7
cpm		0	15	5
k''		0	15	13
pAD		0	15	1
Area		0	15	9
n		0	14	6
EI		0	14	3
RT		0	14	1
UD		0	14	8
VM		0	14	1
kc		0	14	1
C/P		0	14	1
CLi		0	14	3
CMI		0	14	2
KI'		0	14	2
Kid		0	14	6
LWI		0	14	2
TPO		0	14	5
C1.3		0	14	1
Cave	Average plasma concentration	0	14	14
ECLT		0	14	10
ED33		0	14	1
HC10	Concentration required for 10% hemolysis	0	14	1
NLCK		0	14	14
Tmin	Time to reach Cmin	0	14	8
AUC c		0	14	2
AUC p		0	14	2
G0/G1		0	14	11
KDMPC		0	14	2
pLD50		0	14	1
B(DPB)		0	14	1
Pcaco2		0	14	4
Sp Max		0	14	1
K alkyl		0	14	2
Khydrol		0	14	4
Ouabain		0	14	1
Log Pmic		0	14	1
Positive		0	14	6
T/C corr		0	14	5
ALP Level		0	14	1
GOT Level		0	14	1
GPT Level		0	14	1
Peak time		0	14	8
beta t1/2	Terminal half life	0	14	8
Log change		0	14	11
Lysis area		0	14	8
Of control		0	14	13
Ulceration		0	14	2
dose BP/BP		0	14	13
Potentation		0	14	1
Stain index		0	14	2
Amine formed		0	14	3
Free complex		0	14	2
MID log LC50		0	14	2
Nitric oxide		0	14	2
Subcut score		0	14	6
k cat/Kuncat		0	14	8
5-HT syndrome		0	14	6
Abdominal fat		0	14	2
Bleeding time		0	14	10
Drugexcretion	Drug excretion	0	14	14
Edema density		0	14	4
Kidney weight		0	14	5
Mean duration		0	14	4
Net turns/min		0	14	8
POT vigilance		0	14	1
Relative t1/2		0	14	3
GSTCP activity		0	14	5
Histopathology		0	14	4
Max relaxation		0	14	7
No. of plaques		0	14	9
Relative level		0	14	7
max activation	Maximum activation	0	14	2
Adjuvant effect		0	14	7
Average latency		0	14	13
Bilurubin Level		0	14	1
Clonic seizures		0	14	8
Increase in DPM		0	14	8
Peroxidase rate		0	14	1
Serum stability		0	14	14
Bullatacin index		0	14	1
Experimental DPM		0	14	2
Hypocotyl length		0	14	5
Infectious virus		0	14	10
Net grain counts		0	14	2
No. of dogs used		0	14	2
No. of scratches		0	14	10
Plasma histamine		0	14	2
Pressor response		0	14	7
Equilibrium OD340		0	14	4
Log rate constant		0	14	1
Prolactin control		0	14	6
Survivors at 24 h		0	14	14
Complete remission		0	14	8
Control relaxation		0	14	2
Erythema induction		0	14	13
No. of males mated		0	14	12
Photosensitization		0	14	1
Plasma ALT at 24 h		0	14	10
Therapeutic effect		0	14	2
Intrinsic clearance		0	14	8
Liver concentration		0	14	6
Prolactin treatment		0	14	6
Duration of reversal		0	14	1
Growth delay (T-C/C)		0	14	14
Hypotensive activity		0	14	2
No. of dogs reverted		0	14	2
No. of males fertile		0	14	12
Radiation equivalent		0	14	12
Tonic-clonic seizure		0	14	13
Increase over control		0	14	12
Pigmentation capacity		0	14	13
k obs / concentration		0	14	6
Antimicrobial activity		0	14	6
Change in tidal volume		0	14	7
No. of males cohabited		0	14	12
Inhibition potency T/II		0	14	1
Myoblast with parasites		0	14	7
No. protected/ No.dosed		0	14	11
Relative bioavailability		0	14	3
Thermodynamic solubility		0	14	2
Transcriptional activity		0	14	3
Increase in plasma lipase		0	14	6
No. of mice dead/day died		0	14	14
Hind-paw lick latency time		0	14	12
Coronary flow increase (max)		0	14	1
Change in respiratory frequency		0	14	7
Parasites no. per 100 Myoblasts		0	14	7
Increase in blood pressure (P/R)		0	14	1
Inhibitory activity decrease (mean)		0	14	6
Intraocular pressure decrease (max)		0	14	7
Lesion_Clearance		0	13	9
Blockade duration		0	13	5
DNA fragmentation		0	13	12
Hormonal activity		0	13	4
Min concentration		0	13	2
Necrosis response		0	13	4
Progressed tumors		0	13	11
Radioligand bound		0	13	1
Total acid output		0	13	3
Peak concentration		0	13	13
Behavioral response		0	13	4
Log tumor cell kill		0	13	12
Regression response		0	13	6
Vascular relaxation		0	13	2
Exploratory activity		0	13	3
increase in response		0	13	6
Relative cytotoxicity		0	13	4
Relative fluorescence		0	13	4
Anticoagulant activity		0	13	3
Tumor inhibition ratio		0	13	13
DNA single strand breaks		0	13	6
Increase life span (T/C)		0	13	3
Reduction in virus yield		0	13	13
Body weight loss at nadir		0	13	12
Body weight change (day 5)		0	13	2
Spontaneous motor activity		0	13	3
Hepatic necrosis in survivors		0	13	10
Relative stimulatory activity		0	13	3
Differentiation activity ratio		0	13	1
Relative blood pressure potency		0	13	2
Systolic blood pressure change (max)		0	13	1
K5		0	13	2
NE		0	13	7
NR		0	13	4
SB		0	13	8
TO		0	13	13
B/P		0	13	7
BEI		0	13	2
CLm		0	13	2
HIA		0	13	2
Kup	Drug Uptake rate	0	13	1
MRD		0	13	8
TPI		0	13	3
TTO		0	13	11
VFT		0	13	6
E100		0	13	1
ED37		0	13	2
ED70		0	13	5
K OX		0	13	5
KDNB		0	13	1
Vp/F	Apparent peripheral distribution volume	0	13	13
ED250	Effective dose for 250% activity	0	13	1
ICL50		0	13	7
K HOX		0	13	5
LVEDP		0	13	1
ln Kp		0	13	1
ln Kt		0	13	1
EC99.9	Effective concentration for 99.9% activity	0	13	2
Ki int		0	13	11
Log Pa		0	13	2
MED100		0	13	4
RD1000		0	13	6
RSA tR		0	13	1
VOLSYN		0	13	3
Attacks		0	13	9
P value		0	13	2
CL_Ratio		0	13	3
Ip score		0	13	5
Ki slope		0	13	11
C120/ED50		0	13	2
Log cfu/g		0	13	11
MTX ratio		0	13	1
Migration		0	13	7
Ratio pKb		0	13	4
Delta ED50		0	13	4
Log 1/IC90		0	13	1
Photolysis		0	13	2
Urine/bile		0	13	13
Drug deaths		0	13	12
Lung weight		0	13	8
log10PFU/ml		0	13	13
Ki/(Km/Kcat)		0	13	2
Vasodilation		0	13	5
hSlo current		0	13	3
Logit_p(conc)		0	13	2
Oral duration		0	13	2
Shutdown time		0	13	1
Carbonyl group		0	13	9
Cells arrested		0	13	11
T-cell binding		0	13	2
Vagal response		0	13	5
Cell permeation		0	13	1
Chlorine uptake		0	13	1
Max enhancement		0	13	8
Animals affected		0	13	10
Malic enzyme increase		0	12	4
Plasma corticosterone		0	12	2
Threshold active dose		0	12	2
Amount of Ouabain used		0	12	6
Degranulating activity		0	12	10
Intensity of erythemia		0	12	4
Relative concentration		0	12	2
Acetaldehyde Inhibition		0	12	7
Bronchoalveolar lavages		0	12	12
Dose (urinary recovery)		0	12	1
Relative binding potency		0	12	2
No. of animals with damage		0	12	8
No. of mice protected/tested		0	12	12
Complete spontaneous reversal		0	12	1
Mean day of death for total dead		0	12	7
Mean relative surviving fraction		0	12	8
ALAT levels		0	12	6
ASAT levels		0	12	6
CA activity		0	12	4
ERP (delta)		0	12	7
Max release		0	12	1
No. of pits		0	12	4
Observed at		0	12	1
Formaldehyde		0	12	8
GDP activity		0	12	3
GPGB tension		0	12	4
K-1 decrease		0	12	3
PL-017 shift		0	12	2
Peak current		0	12	8
Potency mean		0	12	9
Testosterone		0	12	3
cAMP content		0	12	3
Change in MST		0	12	6
O2 production		0	12	3
Static tumors		0	12	10
T1/2 increase		0	12	4
Urinary level		0	12	3
Control growth		0	12	12
Dopamine level		0	12	8
Fecal recovery		0	12	2
Med tumor area		0	12	11
Platelet count		0	12	2
Potency vs EKC		0	12	2
Time in flight		0	12	7
HbS solubilized		0	12	5
MAO deamination		0	12	2
Mortality range		0	12	12
Relative effect		0	12	2
[3H] TdR uptake		0	12	6
Average activity		0	12	1
Fold change IC50		0	12	6
LH concentration		0	12	12
Myristoylpeptide		0	12	2
Regiospecificity		0	12	11
Unchanged tracer		0	12	4
Vaginal activity		0	12	2
Adjuvant activity		0	12	4
Catalyptic action		0	12	8
Reducing activity		0	12	1
Tumor/blood ratio		0	12	4
Tumor/liver ratio		0	12	4
Untreated control		0	12	2
Cell number change		0	12	2
Distribution ratio		0	12	4
LV dP/dTmax(delta)		0	12	7
Log geometric mean		0	12	9
Relative intensity		0	12	11
Average weight gain		0	12	12
Cell cycle fraction		0	12	12
Protective activity		0	12	12
Spermatogenic index		0	12	12
Transacylation rate		0	12	1
Tumor free survival		0	12	12
Weight gain or loss		0	12	4
Average colony count		0	12	7
Neostigmine reversal		0	12	2
Proconvulsant action		0	12	6
Slope of Schild plot		0	12	1
Logit bioavailability		0	12	1
Macrophage activation		0	12	6
AC		0	12	1
E2		0	12	2
LH		0	12	3
SC		0	12	12
UB		0	12	12
av		0	12	9
GPI		0	12	1
K L		0	12	8
KD1		0	12	3
KD2		0	12	3
MDL		0	12	2
MFI		0	12	3
N/T		0	12	9
PDC		0	12	5
RAP		0	12	2
T/A		0	12	1
TLm	The concentration of toxic substance at which 50 percent of the test animals survive for a specified period of exposure	0	12	1
TVR		0	12	12
CITH		0	12	2
ID25		0	12	4
L-T3		0	12	4
OSAV		0	12	4
VI30		0	12	4
RH/RL		0	12	4
RVmax		0	12	4
Total		0	12	8
logPc	Cationic logP	0	12	1
pKabz		0	12	2
pKapy		0	12	2
Log Ka		0	12	2
Log PI		0	12	3
Log WS		0	12	1
MNTD70	70% maximal non-toxic dose	0	12	1
MNTD90	90% maximal non-toxic dose	0	12	1
T free		0	12	2
10^2 k1		0	12	11
AUC 120		0	12	4
C5a max		0	12	6
Falling		0	12	4
Log Pmw		0	12	1
Log k'o		0	12	2
T bound		0	12	2
lesions		0	12	2
logt1/2	log of Half life	0	12	1
Log [-5]		0	12	3
Log [-6]		0	12	3
Log [-7]		0	12	3
Log [-8]		0	12	3
MES/TEST		0	12	8
Serum TG		0	12	8
TOX/TEST		0	12	10
Urine K+		0	12	4
log10PFU	log10 plaque forming unit	0	12	6
FIC index		0	12	12
Ibuprofen		0	12	2
Log P hep		0	12	1
QTc delta		0	12	7
Urine Na+		0	12	4
AbsAC35_uM		0	12	1
Fe removed		0	12	8
Log 1/E100		0	12	2
Mean value		0	12	9
Osmolality		0	12	6
Protonated		0	12	2
Selective index		0	11	2
Volume of urine		0	11	6
amount in urine		0	11	11
General activity		0	11	6
Lesion frequency		0	11	3
Change of predose		0	11	5
Degradation ratio		0	11	2
Mice with lesions		0	11	11
No. of mice alive		0	11	11
Inflammation units		0	11	4
Logit of 1/deltaCa		0	11	1
Mean rate constant		0	11	8
Resorbing implants		0	11	10
Survival extension		0	11	9
%hepatic blood flow		0	11	7
Psychotropic Effect		0	11	4
Ca2+ binding protein		0	11	5
Binding site fraction		0	11	1
Kinetic_solubility(app)	Apparent kinetic solubility	0	11	1
Mean volume of hind paws		0	11	4
No. of vomiting episodes		0	11	7
Relative phosphorylation		0	11	2
Relative rate metabolism		0	11	1
No. of implants/pregnancy		0	11	10
Body weight change (7 day)		0	11	5
Protein interaction energy		0	11	2
Suppression of parasitemia		0	11	7
Relative inhibitory activity		0	11	2
No. of rats with 5-HT syndrome		0	11	8
Change in No. of trophozoites x 10E-5		0	11	3
CA		0	11	5
CO		0	11	3
Pe		0	11	6
rK		0	11	1
AHV		0	11	3
BGL		0	11	1
D/P		0	11	2
DTH		0	11	4
HAR		0	11	1
IPA		0	11	1
KIs		0	11	2
KT4		0	11	2
KiA		0	11	1
Low		0	11	2
S/T		0	11	10
[A]		0	11	6
kHO		0	11	1
KPCB		0	11	1
NOEL		0	11	2
XL50	Concentration required for 50% cross linking	0	11	6
[EA]		0	11	6
pFe3		0	11	1
2x TT		0	11	1
ClC95		0	11	3
M.A.D		0	11	2
MED99		0	11	1
SEC50		0	11	2
T1/29		0	11	1
pKa,1		0	11	1
pKa,2		0	11	1
Efflux		0	11	6
Extent		0	11	9
K''IAM		0	11	1
Log P'		0	11	1
OD max		0	11	2
Rotorod		0	11	5
Delta Ca		0	11	1
Diuresis		0	11	1
Log 1/Kd		0	11	2
Log Pion		0	11	2
Phosphor		0	11	5
Blood AcH		0	11	2
Log 1/ISA		0	11	1
Tolerance		0	11	10
Hgb levels		0	11	1
Onset time		0	11	6
Ratio_EC50		0	11	4
ATP content		0	11	3
Drug period		0	11	1
Translation		0	11	1
% of control		0	11	10
FR10 control		0	11	1
FR10 treated		0	11	7
log(1/Kiapp)	log(1/Ki(app))	0	11	1
Prolonged ARP		0	11	5
Prolonged VRP		0	11	5
% Max Response		0	11	4
Agonist effect		0	11	7
Change of size		0	11	11
Control period		0	11	3
Dose per organ		0	11	11
Glucose uptake		0	11	5
Onset of block		0	11	11
Max suppression		0	11	6
Gastric lesion score		0	10	2
Gellar cook activity		0	10	10
Glucuronidation rate		0	10	3
Inhibitory potential		0	10	1
Max vasoconstriction		0	10	2
Parasite suppression		0	10	6
Phospholipidosis_MEC		0	10	1
Body weight In. / Fi.		0	10	10
Highest nontoxic dose		0	10	2
Infected erythrocytes		0	10	5
Transacetylation rate		0	10	1
Renal blood flow change		0	10	10
Serum total cholesterol		0	10	10
Phosphorylating activity		0	10	2
Post drug blood pressure		0	10	2
Cytoplasmic vacuolization		0	10	3
Life span increase (mean)		0	10	9
DNA unwinding concentration		0	10	1
Relative substrate velocity		0	10	6
Relative ionotropic activity		0	10	1
Substrate metabolized at 1hr		0	10	10
Alpha-lipoprotein cholesterol		0	10	10
Initial mean arterial pressure		0	10	3
Relative seminal vesicle weight		0	10	5
Force of constriction change (max)		0	10	2
Analgesic efficacy compared to morphine		0	10	1
Analgesic efficacy compared to epibatidine		0	10	1
Log 1/E50		0	10	1
Log k GSH		0	10	1
R/S ratio		0	10	2
Ratio pA2		0	10	4
Substrate		0	10	9
fCmax/MIC		0	10	10
-Log alpha		0	10	1
BAT weight		0	10	3
Clonazepam		0	10	1
Fold shift		0	10	2
HA release		0	10	10
Tumor area		0	10	5
Consumption		0	10	10
M2/M1 index		0	10	2
Mean effect		0	10	2
Peak effect		0	10	2
[I] for Km'		0	10	1
AT1 affinity		0	10	2
Active/total		0	10	10
Damage score		0	10	3
GMS activity		0	10	1
MyristoylCoA		0	10	2
Cell toxicity		0	10	1
HMGR activity		0	10	5
Log TCID50/mg		0	10	10
MAC reduction		0	10	1
Oxygen uptake		0	10	10
Perturbations		0	10	5
cAMP increase		0	10	6
Delta log10CFU		0	10	9
Dose elevation		0	10	2
Iron clearance		0	10	3
Mice In. / Fi.		0	10	9
O2 consumption		0	10	1
Catalepsy score		0	10	7
Cells untreated		0	10	4
Cytochrome loss		0	10	10
GTPase Activity		0	10	4
Inhibition type		0	10	1
Log sensitivity		0	10	2
M-agonist index		0	10	2
Max fall in MAP		0	10	5
Max weight loss		0	10	9
Mean inhibition		0	10	9
Min lethal dose		0	10	1
Relative influx		0	10	2
Induction number		0	10	1
MDH Reactivation		0	10	2
Rate of rotation		0	10	7
Relative ability		0	10	3
Rice stem length		0	10	2
Horizontal screen		0	10	8
Inhibition effect		0	10	1
Tumor half growth		0	10	1
Cytotoxicity index		0	10	6
Induced convulsion		0	10	8
Uptake selectivity		0	10	2
Mean graft survival		0	10	6
No. of tumors/mouse		0	10	5
Survivors at day 60		0	10	10
Amount of metabolite		0	10	5
Carboxylase activity		0	10	10
Concentration_Plasma		0	10	2
Degree of activation		0	10	2
Z		0	10	1
Ac		0	10	4
K3		0	10	4
Si		0	10	2
Tc		0	10	3
pI		0	10	1
rb		0	10	1
C/I		0	10	1
CMT	Calcium mobilization threshold	0	10	2
IAR		0	10	2
Jss		0	10	5
K12		0	10	10
K21		0	10	10
Km'		0	10	1
NTD		0	10	1
PTZ		0	10	6
Pka		0	10	5
R50		0	10	1
TED	Transepidermal Delivery flux	0	10	5
cKi		0	10	2
k'o		0	10	2
k/K		0	10	1
k2c		0	10	2
kA-		0	10	2
kAH		0	10	2
lnK		0	10	2
A/Ad		0	10	5
CMpH		0	10	3
Ctt2		0	10	1
Frel		0	10	1
IC40	Inhibitory concentration for 40% activity	0	10	7
Kon1		0	10	1
Kon2		0	10	1
METD		0	10	2
PKa1		0	10	1
PKa2		0	10	1
TMSW	Time interval within mutant selection window	0	10	10
pC30		0	10	3
BBC50	Biofilm Bactericidal Concentration for 50% actvity	0	10	2
Bmax1		0	10	4
Cp(T)	Terminal plasma concentration	0	10	10
Koff1		0	10	1
Koff2		0	10	1
Tlast	Time of last measurable concentration	0	10	10
cLogP		0	10	1
k3/k1		0	10	3
pH1/2		0	10	2
C10 N2		0	10	8
K Bapp		0	10	3
Median		0	10	10
Sigmap		0	10	1
logCMC	Log(Critical micelle concentration)	0	10	1
AUC max		0	10	1
K13+K23		0	10	10
Log P16		0	10	1
T>MIC90		0	10	10
Writhes		0	10	7
k'/k'+1		0	10	2
Delta LV		0	10	1
Function		0	10	2
CPM x1000		0	10	2
Efflux Ki		0	10	2
Emesis_EC		0	10	6
Intensity		0	10	5
First adverse effect		0	9	7
Intrinsic solubility		0	9	1
Ratio_cerebrum/blood		0	9	4
Therapeutic efficacy		0	9	9
Trabecular thickness		0	9	9
Anticonflict activity		0	9	8
Content of cell cycle		0	9	3
Eicosanoid production		0	9	5
Ratio_cerebellum/blood		0	9	4
Relative thymus weight		0	9	1
Acute Therapeutic Index		0	9	1
No. of protected/tested		0	9	2
Relative adrenal weight		0	9	1
Threshold concentration		0	9	2
Endosteal eroded surface		0	9	9
Propioaldehyde generated		0	9	3
Derived trabecular number		0	9	8
Animals survived >6 months		0	9	5
Cutaneous toxicology score		0	9	3
Directly measured thickness		0	9	9
Total peripheral resistance		0	9	4
Vascular accumulation ratio		0	9	1
Derived trabecular thickness		0	9	9
Concentration of max response		0	9	2
Antiinflammatory change (mean)		0	9	1
Endosteal mineralizing surface		0	9	9
Periosteal mineralizing surface		0	9	9
No. of axonal branch points/cell		0	9	3
Periosteal mineral apposition rate		0	9	8
Body weight change (average weekly)		0	9	9
Occlusions		0	9	6
Responders		0	9	9
Simulation		0	9	2
Approx. pKa		0	9	1
Hypotension		0	9	9
Log10 CFU/g		0	9	8
Marrow area		0	9	9
No. partial		0	9	6
ST/CB ratio		0	9	6
Tissue area		0	9	8
Toxic/total		0	9	9
GST activity		0	9	9
HDL-C change		0	9	3
PT extension		0	9	1
Urine output		0	9	3
Cells sickled		0	9	3
Corpora lutea		0	9	5
Flaking score		0	9	3
Onset seizure		0	9	9
Rate of death		0	9	4
Reaction rate		0	9	6
Recovery rate		0	9	4
Sensitisation		0	9	1
Stroke volume		0	9	9
Abrasion score		0	9	3
Acid secretion		0	9	2
Challenge dose		0	9	3
DA utilization		0	9	1
Fold reduction		0	9	1
Fold_reduction		0	9	3
Graft survival		0	9	7
Maxi-K current		0	9	4
Mu/delta ratio		0	9	1
No. of ferrets		0	9	7
No. of strains		0	9	6
Trabecular no.		0	9	9
% of NO release		0	9	5
Glucuronidation		0	9	2
Infection score		0	9	6
Kinase activity		0	9	2
Na+ restoration		0	9	1
Prodrug remains		0	9	4
Vehicle control		0	9	1
Binding Decrease		0	9	1
Mortality number		0	9	9
Na+ inactivation		0	9	4
Primary response		0	9	1
Control death day		0	9	7
Pressure decrease		0	9	7
rate constant app		0	9	2
Gastriculcer index		0	9	1
Light transmission		0	9	3
No. pregnant/mated		0	9	8
Recovered in urine		0	9	9
Secondary response		0	9	1
Social interaction		0	9	6
Acetylcholine level		0	9	1
Amylase stimulation		0	9	1
Concentration_brain		0	9	9
Decay-time constant		0	9	9
Minimum single dose		0	9	3
Antiamnesic activity		0	9	9
Connectivity density		0	9	9
Control tumor volume		0	9	7
AE		0	9	9
AQ		0	9	1
DC	Distribution Co-efficient	0	9	1
Pa		0	9	1
Pt		0	9	1
T2		0	9	9
TW		0	9	9
tz	Time of the last sample which has an analytical quantifiable concentration	0	9	5
CLP		0	9	8
COF		0	9	9
Css	Drug concentration at steady state	0	9	6
DSB		0	9	1
FRE		0	9	3
GFR		0	9	7
HDL		0	9	5
HHP		0	9	2
K A		0	9	1
LDL		0	9	4
MRC	Minimum restrictive concentration	0	9	3
PDR		0	9	1
PKB		0	9	3
PRL		0	9	2
TAI		0	9	5
AC30		0	9	3
TC90	Toxic concentration of drug causing 90% reduction in cell viability	0	9	2
TE50		0	9	1
pKa5		0	9	8
APD70		0	9	3
SubG0		0	9	9
Vagus		0	9	2
k2/KI		0	9	2
khydr		0	9	6
logPi	Ionic logP	0	9	1
INCC50	50% Inhibition of number of the colonies	0	9	9
Log Dm		0	9	1
T1/2 h		0	9	4
cLogPb		0	9	1
2x aPPT		0	9	1
C10 air		0	9	7
Log GTI		0	9	1
MPC/MIC		0	9	3
Predrug		0	9	4
Chelator		0	9	9
I / E100		0	9	3
Implants		0	9	5
Log D5.5		0	9	1
Postdrug		0	9	4
Pregnant		0	9	5
Reaction		0	9	1
Tetramer		0	9	6
[ALP]max		0	9	1
[LDH]max		0	9	1
k cat/Ki		0	9	1
AUC total		0	9	8
Amplitude		0	9	3
K+ output		0	9	3
Log ratio		0	9	1
Permeated		0	9	2
Unwinding		0	9	8
Ca2+ serum		0	9	2
Chronic TI		0	9	1
Lysis time		0	9	4
Max change		0	9	9
Na+ output		0	9	3
Tissue swelling		0	8	8
[Ca2+] increase		0	8	2
Arrhythmia score		0	8	1
Calculated Ratio		0	8	1
Platelets x10e-3		0	8	7
Ratio CIC95/IC50		0	8	1
Reduction in AUC		0	8	3
Tumor inhibition		0	8	7
Anti-fXa activity		0	8	4
Atherogenic index		0	8	2
Cumulative amount		0	8	2
Cysteine reaction		0	8	1
Dose modification		0	8	1
Lipoprotein level		0	8	2
NSR survival rate		0	8	1
No. of pits/slice		0	8	8
Receptor occupied		0	8	8
Supressive effect		0	8	2
Vocalization time		0	8	1
Average proportion		0	8	8
Change in LV dp/dt		0	8	4
Diffusion analysis		0	8	7
Max uterine weight		0	8	7
Normal weight gain		0	8	1
Selectivity rating		0	8	3
Amount incorporated		0	8	8
Boron concentration		0	8	8
Boron incorporation		0	8	4
Diazepam antagonism		0	8	3
ID (per g of femur)		0	8	2
Log cfu/g of tissue		0	8	5
Uterotonic activity		0	8	2
tRNA peak exclusion		0	8	2
Microsomal stability		0	8	4
Hypocalcemic activity		0	8	1
Mean total resorption		0	8	8
Reserpine hypothermia		0	8	1
Adrenochrome formation		0	8	2
Relative Potency Ratio		0	8	3
Control of P-450 marker		0	8	8
Latency to step through		0	8	7
Progesterone production		0	8	1
Proportion of survivors		0	8	8
Contractility (LV dP/dt)		0	8	8
Enantiomeric composition		0	8	4
Median retension latency		0	8	8
Rate of hydride transfer		0	8	8
Apparent binding constant		0	8	5
No. of killed or paralyzed		0	8	3
Revertant colonies per plate		0	8	8
alkaline phosphatase activity		0	8	6
Ratio of depolarizing activity		0	8	2
Max fall		0	8	2
Of HDL-C		0	8	3
Papp e-6		0	8	1
Property		0	8	2
Severity		0	8	6
-ln (MIC)		0	8	1
88Y-serum		0	8	3
Delta FFA		0	8	1
Delta I/I		0	8	1
Diffusion		0	8	1
Extension		0	8	4
HSA shift		0	8	1
Krelative		0	8	1
Quenching		0	8	1
Ratio I/P		0	8	1
HCMV yield		0	8	8
Log effect		0	8	6
Mass index		0	8	7
Morphology		0	8	3
Total rate		0	8	2
dp/dt(max)		0	8	2
K app ratio		0	8	2
Ke naloxone		0	8	1
MDA content		0	8	3
RBC x 10e 3		0	8	5
Restoration		0	8	4
log(1/LD50)		0	8	1
CAT activity		0	8	1
Deiodination		0	8	4
ITI activity		0	8	5
Of non-HDL-C		0	8	3
Skin scaling		0	8	1
Basal control		0	8	1
Human potency		0	8	1
Hyperactivity		0	8	1
Hypermotility		0	8	7
LD50 increase		0	8	4
Log P/(100-P)		0	8	1
Mean pit size		0	8	8
Mean reaction		0	8	4
Mean response		0	8	8
NADH oxidized		0	8	2
Oligo shifted		0	8	1
Skin response		0	8	2
Thermogenesis		0	8	4
Volume change		0	8	7
Volume of air		0	8	8
betat1/2(app)	Apparent terminal half life	0	8	7
t1/2 lambda z	Apparent half-life of the terminal disposition phase	0	8	4
Active culture		0	8	8
Cardiac output		0	8	7
Fever response		0	8	1
Ki(1.8x10e-11)		0	8	2
Oligo modified		0	8	1
Relative to DA		0	8	1
Rotations/10 h		0	8	2
Weight at term		0	8	7
rT3 Production		0	8	4
Blood clearance		0	8	8
Cmax_metabolite		0	8	6
Increase (Emax)		0	8	1
Lethal toxicity		0	8	8
Reduction in TG		0	8	2
Renal clearance		0	8	4
BW		0	8	8
DW		0	8	1
Du		0	8	2
G1		0	8	4
AAL		0	8	2
ADD		0	8	8
ALT		0	8	8
CLT		0	8	8
D-2		0	8	3
HPB		0	8	1
I/E		0	8	3
I80		0	8	5
IC0		0	8	2
K m		0	8	2
K-2		0	8	5
LSD		0	8	4
M/T		0	8	7
MPD		0	8	1
R+V		0	8	3
RBC		0	8	7
ROR		0	8	1
RRI		0	8	1
TAD		0	8	2
TPR		0	8	6
V/K		0	8	3
k-1		0	8	3
Cdyn		0	8	7
Dobs		0	8	1
ED60		0	8	4
IC27	Concentration required for 27% inhibition	0	8	1
Ki.c		0	8	3
Kina		0	8	4
LD40	Lethal dose for 40% activity	0	8	1
NSVT		0	8	5
Vsss		0	8	1
pBBB	Blood brain barrier permeability	0	8	2
pEMR		0	8	1
AUCss		0	8	4
Bmax2		0	8	3
CC50%		0	8	2
EDmax		0	8	1
K off		0	8	4
Km/Ki		0	8	2
LDL-C		0	8	1
pEC90	-log (DY90)	0	8	8
Active		0	8	6
Cmaxss		0	8	4
Cmedia		0	8	2
DFMBMD		0	8	1
Free C		0	8	1
I/IC50		0	8	1
K DMPC		0	8	3
K DMPG		0	8	3
LD app		0	8	1
MBIC50	Minimum inhibitory concentration causing 50% reduction in biofilm formation	0	8	1
Cocaine		0	8	2
Delta F		0	8	2
Delta K		0	8	1
Density		0	8	6
Log K'w		0	8	1
Log PTA		0	8	1
Log TCI		0	8	1
t1/2abs	Absorption half-life	0	8	8
Helicity		0	8	2
Change in mean aortic flow		0	7	7
Modification of adsorbed drug		0	7	1
Activity of NADH dehydrogenase		0	7	4
Relative rate of decomposition		0	7	3
Decrease in No. of avoidence responses		0	7	7
Dose effecting a 20mmHg change in diastolic blood pressure		0	7	2
Depression		0	7	1
Log 1/ED30		0	7	1
PFC/spleen		0	7	7
Pupil size		0	7	5
D2 duration		0	7	1
Offset time		0	7	6
PIC seizure		0	7	2
Acceleration		0	7	1
Antidiuretic		0	7	3
CNS activity		0	7	1
Damaged area		0	7	2
GABA agonism		0	7	5
Lesion index		0	7	3
Max efficacy		0	7	6
Amount formed		0	7	1
Saftey margin		0	7	1
Time to onset		0	7	6
Absolute ratio		0	7	1
Antibody titer		0	7	3
Avoidance time		0	7	2
Blood Pressure		0	7	2
DTT inhibition		0	7	1
Depolarisation		0	7	5
Group toxicity		0	7	2
NO2- (mol/mol)		0	7	2
Time to offset		0	7	4
Unreacted drug		0	7	4
Cell saturation		0	7	6
Change in dP/dt		0	7	7
Oxygen consumed		0	7	3
Writhing number		0	7	2
Fold stimulation		0	7	2
Lactate produced		0	7	5
Mean aortic flow		0	7	7
Mitogenic effect		0	7	3
Pyrogenic effect		0	7	4
Receptor binding		0	7	1
Induced frequency		0	7	7
Oxytocic activity		0	7	4
DNA peak exclusion		0	7	1
Erythema intensity		0	7	1
Increase in [Ca+2]		0	7	2
Vomiting frequency		0	7	7
cell kill activity		0	7	2
Repolarization time		0	7	1
HCMV yield reduction		0	7	7
Irreversible binding		0	7	4
Melanotropic potency		0	7	4
Hypnosis potentiation		0	7	1
Max contractile force		0	7	1
Melanotropic activity		0	7	3
Motor activity change		0	7	7
Relative liver weight		0	7	7
Virus yield reduction		0	7	7
Anti-infectious effect		0	7	3
Duration of immobility		0	7	1
Incidence of occlusion		0	7	7
Specific radioactivity		0	7	3
Change in stroke volume		0	7	7
Free radical scavenging		0	7	1
Oxygen consumption rate		0	7	4
Parasite_Clearance_time		0	7	2
Intrinsic vasorelaxation		0	7	1
Funbound_liver_microsomes		0	7	3
Ba		0	7	6
Cz	last analytical quantifiable concentration	0	7	4
E0		0	7	2
NC		0	7	3
Rn		0	7	1
T3		0	7	3
kH		0	7	4
C/T		0	7	7
CPI	Critical pressure of insertion	0	7	1
ClB		0	7	2
ClM		0	7	1
FLT		0	7	1
IE1		0	7	1
KII		0	7	3
Ka1		0	7	5
Kun		0	7	1
Mrt		0	7	1
Ctau	Drug concentration at the end of dosing interval	0	7	7
Fmax		0	7	1
GR50	Compound concentration for 50% growth reduction	0	7	1
ID30		0	7	3
LD95		0	7	2
MCHC		0	7	4
T.I.		0	7	4
kC,U		0	7	1
pKHB		0	7	1
2x TG		0	7	2
CIC90		0	7	1
ILS40		0	7	2
NTD50		0	7	2
Papps		0	7	1
ft1/2	Half life of free unbound fraction	0	7	6
k act		0	7	1
pCB50		0	7	1
pEC20		0	7	2
pIC30		0	7	2
Ka(T4)		0	7	2
Log Pc		0	7	1
Spread		0	7	1
rel ko		0	7	5
sigmaH		0	7	6
sigmaL		0	7	5
Delta I		0	7	1
Ki(app)	Apparent inhibition constant	0	7	3
MED99.9		0	7	3
Profile		0	7	4
CBF-ID75		0	7	1
CIC IC50		0	7	1
LAL test		0	7	4
LLR msad		0	7	5
Log Dmax		0	7	2
Log rate		0	7	1
Max Uosm		0	7	2
Platelet		0	7	6
Resowing		0	7	4
pA2-pA10		0	7	2
-Log KD50		0	7	2
AUC ratio		0	7	3
CMV yield		0	7	7
Lambda-em		0	7	2
Lambda-ex		0	7	2
TD50/ED50		0	7	1
Vdss(app)	Apparent volume of distribution at steady state	0	7	7
Block time		0	7	1
Bitter taste intensity		0	6	6
Increase contractility		0	6	6
Inhibition tumor index		0	6	2
Molar primaquine Index		0	6	1
Amount of [3H]thymidine		0	6	3
CBF increasing activity		0	6	1
Relative threshold dose		0	6	3
Antiproliferative effect		0	6	1
Fungicidal concentration		0	6	1
Plaque inhibition result		0	6	2
Rate of turbidity change		0	6	1
Spermidine concentration		0	6	6
Synergy with methicillin		0	6	3
Topoisomerase-I activity		0	6	1
Average for skin reaction		0	6	3
Immunosupressive activity		0	6	5
Inhibitory activity ratio		0	6	2
Average turns/first 15 min		0	6	1
Denaturation rate constant		0	6	2
Final plasma concentration		0	6	2
Relative analgesic potency		0	6	1
Relative dissociation rate		0	6	2
Change of hemoconcentration		0	6	1
Distribution of excreted Fe		0	6	2
Peak radioactivity in blood		0	6	2
No. of shocks accepted/5 min		0	6	2
Relative metabolic stability		0	6	3
Electrophysiological activity		0	6	1
Respiratory system resistance		0	6	6
Relative uterotrophic activity		0	6	2
Cellular uptake of boron at 16h		0	6	1
Reduction in respiratory volume		0	6	5
Approximate colony formation unit		0	6	3
Neurite bearing cells/total cells		0	6	6
D2 selectivity		0	6	1
Fallen/treated		0	6	4
Antinociception		0	6	6
Cell aggregates		0	6	2
FPTase activity		0	6	6
Latency to exit		0	6	5
Lesion coverage		0	6	5
No. of relapses		0	6	4
Onset for sleep		0	6	2
Peak inhibition		0	6	6
Protein content		0	6	3
Rescued neurons		0	6	6
Retraction time		0	6	4
Time of licking		0	6	6
Cellular content		0	6	3
Culture negative		0	6	2
Decrease in tone		0	6	3
GABA enhancement		0	6	5
Reduction of IOP		0	6	1
Static remission		0	6	2
Activity regained		0	6	3
Conjugation ratio		0	6	1
Control of growth		0	6	6
Developed tension		0	6	4
Hypochromic shift		0	6	1
Relative response		0	6	6
Reverse potential		0	6	1
Threshold current		0	6	4
Thymidylate shift		0	6	2
cpm/million cells		0	6	6
Antagonism effects		0	6	5
Avoidance response		0	6	6
Bathochromic shift		0	6	1
Drug mol/base pair		0	6	6
Feeding deterrency		0	6	5
Glycine antagonism		0	6	4
Irritation of eyes		0	6	2
Membrane integrity		0	6	1
Ratio_[3H]:tubulin		0	6	6
Time over 100ng/ml		0	6	1
50% naproxen formed		0	6	1
Antigen p24 content		0	6	2
Concentration_urine		0	6	5
Control cell number		0	6	6
Duration of plateau		0	6	3
Fibers/preparations		0	6	4
Observed relaxivity		0	6	2
Pancreatic response		0	6	6
Prolongation effect		0	6	3
Remaining at 40 min		0	6	3
Bone mineral density		0	6	4
Boron in media at 0h		0	6	1
Convulsion threshold		0	6	2
Exploration motility		0	6	4
Heart rate (initial)		0	6	2
Hepatocyte stability		0	6	2
Loss of inactivation		0	6	6
Relative Selectivity		0	6	2
Residual RR activity		0	6	6
Time to peak tension		0	6	3
Change in sensitivity		0	6	1
Max platelet response		0	6	2
Median tumoral volume		0	6	6
Relative permiability		0	6	1
k-1 app		0	6	1
pD2 app		0	6	4
AUC 1/T1		0	6	1
AUC conc		0	6	1
Abortion		0	6	6
Alpha 50		0	6	4
Caverage		0	6	2
Delta TG		0	6	5
KCS, APP		0	6	6
Log Palk		0	6	1
Log beta		0	6	1
MHPG_SO4		0	6	6
OMNI med		0	6	1
TPO(max)		0	6	2
Vmax rel		0	6	2
AUC units		0	6	2
Depletion		0	6	3
Max dV/dt		0	6	6
Mean ED50		0	6	1
Na+ ratio		0	6	1
TG 2X lag		0	6	2
Total DPM		0	6	1
Transport		0	6	1
Blood loss		0	6	2
Cmax_tumor		0	6	4
Heart Rate		0	6	1
Relaxivity		0	6	1
Thr uptake		0	6	5
Acetylation		0	6	1
Hexobarb ST		0	6	3
RT activity		0	6	2
Rat turning		0	6	1
Relative Km		0	6	2	BAO_0000477 (Km)?
Virus titer		0	6	1
CAI activity		0	6	1
Cr secretion		0	6	1
GH AUC 0-180		0	6	1
Iron binding		0	6	1
NAD+ content		0	6	3
Net Swelling		0	6	6
PCP activity		0	6	2
Agonist index		0	6	2
Average ratio		0	6	1
Blood lactate		0	6	6
Change in FVR		0	6	6
Change in MAP		0	6	3
Change in TPR		0	6	6
Ear thickness		0	6	4
Egg reduction		0	6	4
FACO Activity		0	6	3
Fbound_plasma		0	6	6
Free fraction		0	6	3
Gastric score		0	6	3
HCl Secretion		0	6	5
Mean activity		0	6	4
Midpoint dose		0	6	2
No. of spikes		0	6	5
Rat fertility		0	6	6
Reversibility		0	6	6
Rotorod index		0	6	1
Serum glucose		0	6	6
Basis motility		0	6	4
C10 air/C10 N2		0	6	3
Cells infected		0	6	2
t		0	6	2
Kc		0	6	3
Kw		0	6	1
LV		0	6	5
SA		0	6	5
ks		0	6	6
BAV		0	6	3
COI		0	6	1
Cli		0	6	2
DMF		0	6	1
DR2		0	6	4
EPS		0	6	6
GRI		0	6	1
HDT		0	6	5
ILC		0	6	2
K+2		0	6	2
MSC		0	6	1
MTT	Mean transit time	0	6	6
NED		0	6	1
ROI		0	6	2
SNA		0	6	6
TCT		0	6	3
d50		0	6	3
k+2		0	6	1
pA1		0	6	1
pKH		0	6	2
pKL		0	6	2
AD99		0	6	1
CC20	Concentration required for 20% cytotoxicity	0	6	1
CLup	Tissue uptake clearance	0	6	6
EMax		0	6	2
FR50	Feeding ratio when 50% of control leaf disk area consumed	0	6	1
GI25	Concentration for 25% growth inhibition	0	6	1
High		0	6	1
IogP		0	6	2
K Tm		0	6	4
PRCF		0	6	1
TMED		0	6	3
VLDL		0	6	1
Xi50		0	6	1
pC20		0	6	2
rapp		0	6	1
CFU/g	CFU/g	0	6	6
Ep2/2		0	6	1
Kkmax	Rate constant for maximal microbial kill	0	6	4
Occ80		0	6	1
PCoct		0	6	2
RD100		0	6	2
U osm		0	6	3
k+2/k		0	6	1
1/krel		0	6	2
3D PSA		0	6	1
K+2/Ki		0	6	3
Vdss/F		0	6	6
k1 obs		0	6	1
k2 obs		0	6	1
AUC Npo		0	6	5
Ext AUC		0	6	2
GH peak		0	6	1
Log MrI		0	6	1
Log d50		0	6	3
Nitrate		0	6	1
Nitrite		0	6	1
P ratio		0	6	1
ED50 / ED50 (taxol)		0	5	3
No. of lung lesions		0	5	4
Residual amine (ee)		0	5	1
Rotational behavior		0	5	5
Surface involvement		0	5	2
Acetylcholine change		0	5	1
Bioavailability_oral		0	5	2
Hepatic triglyceride		0	5	5
Max agonist activity		0	5	5
Progressed remission		0	5	1
Substrate efficiency		0	5	1
Vasopressor activity		0	5	3
Isometric contraction		0	5	1
Max protective effect		0	5	2
No. of virus free mice		0	5	5
Phospholipidosis_index		0	5	5
Carbamoylating activity		0	5	1
Control survivals/total		0	5	5
Correlation coefficient		0	5	4
No. of open arm entries		0	5	4
Plasma cholesterol total		0	5	3
Relative loss of potency		0	5	1
Amount Recovered in urine		0	5	5
IP3-sensitive Ca2+ stores		0	5	2
Ca2+ antagonistic activity		0	5	1
Animals with palpable tumor		0	5	5
Fraction Recovered in urine		0	5	5
Relative antitumor activity		0	5	1
Negative ionotropic activity		0	5	2
No. of guinea pigs protected		0	5	3
Peripheral restriction index		0	5	1
Reduction in prostate weight		0	5	2
Enantioselectivity coefficient		0	5	5
Negative chronotropic activity		0	5	2
Arterial blood pressure decrease		0	5	5
Decrease in heart norepinephrine		0	5	5
Inhibition of increase in weight		0	5	1
Coronary perfusion pressure change		0	5	2
No. of rats displaying DA syndrome		0	5	5
Coronary vascular resistance decrease		0	5	1
Decrease in hypothalamus norepinephrine		0	5	5
Mean no. of days post-infection to death		0	5	3
Relative		0	5	2
Serum T4		0	5	5
Vmax / K		0	5	1
Cmax/Tmax		0	5	5
Delta H-V		0	5	2
Delta S-H		0	5	2
Half time		0	5	1
Max score		0	5	5
Morbidity		0	5	2
Oxidation		0	5	2
Remission		0	5	5
Sterility		0	5	3
TC50/IC50		0	5	1
AUC 0-time		0	5	3
CFR rating		0	5	5
K inact/Km		0	5	1
Plasma MIC		0	5	2
IP+SC score		0	5	1
Sleep ratio		0	5	1
Uptake rate		0	5	1
s-GOT level		0	5	2
s-GPT level		0	5	2
Apparent_pKa	Apparent pKa (negative logarithm of acid association constant)	0	5	2
DBP/UP ratio		0	5	2
IOP lowering		0	5	3
Lesion score		0	5	1
MeAIB uptake		0	5	5
Mobilization		0	5	2
Toxic effect		0	5	1
Cells invaded		0	5	5
Infusion rate		0	5	5
Mean log LC50		0	5	3
Molar potency		0	5	1
Observed [pt]		0	5	1
Positive paws		0	5	5
SGOT activity		0	5	1
SGPT activity		0	5	1
Uterus effect		0	5	5
Adrenal uptake		0	5	5
Choline uptake		0	5	4
Cross reaction		0	5	1
Exudate volume		0	5	2
Apoptotic cells		0	5	4
IL-1 production		0	5	3
Mitotic figures		0	5	5
Phosphorylation		0	5	1
Agonist response		0	5	2
Ambulation score		0	5	5
Loss of affinity		0	5	3
Max potentiation		0	5	1
No. of avoidance		0	5	4
Of dose excreted		0	5	5
Thy-1 expression		0	5	3
damage reduction		0	5	1
Anesthetic effect		0	5	4
Bicarbonate level		0	5	3
Delta APD90 (max)		0	5	3
Epinephrine level		0	5	4
Epoxide formation		0	5	5
Platelet count/ul		0	5	5
Average 14-day MGR		0	5	5
Virus inactivation		0	5	3
Antifungal activity		0	5	4
Behavioral syndrome		0	5	3
%		0	5	3
X		0	5	2
C2		0	5	5
Kf		0	5	4
Kh		0	5	2
ME		0	5	1
TD		0	5	1
Ts		0	5	1
VI		0	5	5
1/n		0	5	1
AAC	Area above the microbial killing curve	0	5	5
AOC		0	5	1
BUI		0	5	1
CLd	Distribution clearance	0	5	5
DFM		0	5	5
I40		0	5	2
ICA		0	5	1
Khd		0	5	1
Kix		0	5	3
PPM		0	5	4
SDS		0	5	5
SWo		0	5	1
pK4		0	5	3
Cpss	Plasma concentration at steady state	0	5	5
DR20		0	5	1
IPol		0	5	1
KHOX		0	5	3
Kieq	Equilibrium inhibition constant	0	5	2
Kpol		0	5	1
MRTV		0	5	5
PVCs		0	5	4
pEC5		0	5	5
ABD50		0	5	1
C 8 h		0	5	1
EBD20		0	5	2
ED1/3		0	5	2
I50 M		0	5	2
pIC35		0	5	1
AUC po		0	5	1
K beta		0	5	1
Vm rel		0	5	2
AUC 100		0	5	1
B-A/A-B		0	5	1
LD/ED80		0	5	1
S-phase		0	5	1
Tubulin		0	5	1
[I] 0.5		0	5	2
p value		0	5	3
AUC ED50		0	5	1
AUC last		0	5	2
AV block		0	5	3
Absolute		0	5	1
C10APD90		0	5	4
Cmax_PTH		0	5	5
Dilation		0	5	5
ED delta		0	5	2
HTS data		0	5	3
Impaired		0	5	5
Infected		0	5	3
KD hydro		0	5	2
Log 1/KL		0	5	2
Log Ko/w		0	5	1
Log Pcyc		0	5	1
Necrosis		0	5	5
Relative initial rate		0	4	1
Serum creatinine conc		0	4	3
Serum prolactin level		0	4	3
Behavioral observation		0	4	4
Competitive protection		0	4	3
Critical concentration		0	4	1
Functional selectivity		0	4	2
Hydroxyproline release		0	4	4
Radioactivity in urine		0	4	4
Reduction in EOS count		0	4	4
Relative initial slope		0	4	1
Specific incorporation		0	4	4
Max uterotonic response		0	4	1
Amount of TXB2 formation		0	4	2
Axonal regeneration rate		0	4	4
No. of rats with lesions		0	4	4
Velocity relative to ATP		0	4	1
Relative activity of AChE		0	4	4
Thylpositive cells/spleen		0	4	2
Time of half inactivation		0	4	4
Increase life span (mg/kg)		0	4	2
No. of mice infected /total		0	4	4
Respiratory activity change		0	4	3
Urea Nitrogen Concentration		0	4	3
Changes in airway resistance		0	4	4
Fraction of Liver Blood Flow		0	4	3
Changes in dynamic compliance		0	4	4
Relative phosphorylation rate		0	4	4
Change in foot-licking latency		0	4	3
Margin before onset of hypokalemia		0	4	3
Margin before onset of tachycardia		0	4	2
Diastolic blood pressure decrease (30%)		0	4	3
partition_ratio		0	4	2
Actual clearance		0	4	4
Cortex_Clearance		0	4	1
Gross morphology		0	4	4
Mean axonal area		0	4	4
PP2A Selectivity		0	4	1
Paraparetic mice		0	4	1
Peak effect time		0	4	3
Residue fraction		0	4	4
Serum creatinine		0	4	4
Tumor free/total		0	4	4
Vacuole response		0	4	1
Aggregation ratio		0	4	1
Antibody response		0	4	1
Behavior response		0	4	3
Concentration_CSF		0	4	3
Cytotoxicity IC50		0	4	2
Formation of NO3-		0	4	2
Inhibition period		0	4	1
Lowering activity		0	4	3
Max contractility		0	4	4
Mean paw diameter		0	4	1
Naproxen produced		0	4	4
No. of WDS/60 min		0	4	4
Oral availability		0	4	3
Percent remaining		0	4	2
Permeability rate		0	4	4
5-HTP accumulation		0	4	4
Cooperative effect		0	4	1
Displacement of DP		0	4	1
Erythema formation		0	4	2
Lactose production		0	4	1
Monocation species		0	4	1
Subcutaneous score		0	4	1
Thylpositive cells		0	4	2
Thymidine reversal		0	4	1
Ventricular MAPD90		0	4	4
Apoptosis induction		0	4	2
Average body weight		0	4	1
Average lung weight		0	4	1
Cyclase stimulation		0	4	2
Duration of seizure		0	4	2
Exhalation of 14CO2		0	4	4
External nucleoside		0	4	2
No. of uptake sites		0	4	2
Plasma triglyceride		0	4	4
Relative efficiency		0	4	4
Relative to control		0	4	2
Infertility activity		0	4	2
Inhibition potential		0	4	1
Intraperitonal score		0	4	1
Peak striatal uptake		0	4	1
Primary tumor weight		0	4	4
Prodrug reconversion		0	4	4
Punishment test msad		0	4	2
Ratio of stimulation		0	4	2
Temperature increase		0	4	2
Total infarct volume		0	4	4
Total urine activity		0	4	4
Acute lethal toxicity		0	4	4
Antiviral selectivity		0	4	4
Carotid Flow Decrease		0	4	1
Formation of compound		0	4	1
Heart weight absolute		0	4	1
k eff (rel)		0	4	3
%Bound_brain		0	4	1
Augmentation		0	4	1
BG reduction		0	4	4
Brain lesion		0	4	4
C5a affinity		0	4	2
DNA fraction		0	4	1
Delta TCID50		0	4	1
Delta logP50		0	4	1
Fecal weight		0	4	4
PAO activity		0	4	3
Rats turning		0	4	2
ST elevation		0	4	2
Total uptake		0	4	2
ADP formation		0	4	1
Atrial MAPD90		0	4	4
Basal binding		0	4	2
DNA on filter		0	4	4
Ferret emesis		0	4	4
Level of cGMP		0	4	4
Limiting t1/2		0	4	1
Molar content		0	4	1
Ratio (Ci/Ce)		0	4	1
Ratio of dose		0	4	2
S/Cereb Ratio		0	4	4
Severity mean		0	4	4
Synaptic site		0	4	4
Total protein		0	4	4
Total release		0	4	1
Total tritium		0	4	1
Unmetabolized		0	4	1
pH dependence		0	4	4
-Log IC50/IC50		0	4	1
Activity Score		0	4	2
Analogue level		0	4	3
Anticonvulsant		0	4	3
Change of area		0	4	4
Control vomits		0	4	4
Dose converted		0	4	2
EOS inhibition		0	4	4
Gastric damage		0	4	1
IMPDH activity		0	4	3
Log inhibition		0	4	2
Log10 CCID50/g		0	4	4
Receptor state		0	4	4
Response value		0	4	1
Sign free dose		0	4	1
Skin thickness		0	4	4
Zone reduction		0	4	2
Activity Factor		0	4	1
Binding potency		0	4	3
Cartilage space		0	4	1
Control retches		0	4	4
Desensitisation		0	4	1
Fraction change		0	4	2
Growth response		0	4	2
Internalisation		0	4	1
Irreversibility		0	4	1
Log10 reduction		0	4	1
Of rats turning		0	4	2
Plasma integral		0	4	1
Protective dose		0	4	2
Ring immobility		0	4	4
Tubulin content		0	4	1
ka/kr		0	4	3
rel T		0	4	1
1/kmax		0	4	3
Clones		0	4	4
Ki/K'i		0	4	1
Ks app		0	4	2
Kuncat		0	4	4
Lesion		0	4	3
Log PC		0	4	1
MRTinf		0	4	1
Vomits		0	4	4
[A]T,L	Normalized affinity index at given temperature and ligand concentration	0	4	2
AUC 0-8		0	4	2
AUC glu		0	4	4
AUC nom		0	4	2
Albumin		0	4	3
CL free	Hepatic Clearance for the unbound fraction of the drug	0	4	3
DA stim		0	4	2
ED10 HR		0	4	4
EPS MED		0	4	1
Kr/kmax		0	4	3
Log A50		0	4	2
Protein		0	4	4
Retches		0	4	4
T/C (d)		0	4	2
Va beta		0	4	4
kaKr/kr		0	4	3
AUC 0-4h		0	4	3
Basal GH		0	4	3
CFU-GEMM		0	4	2
Catalase		0	4	3
Erosions		0	4	1
Fraction		0	4	2
ILS days		0	4	1
Log [-9]		0	4	2
Occ ED50		0	4	2
ATP level		0	4	2
Cmin_PBMC		0	4	4
I/M ratio		0	4	3
KA effect		0	4	2
Log [-10]		0	4	1
MTD ratio		0	4	1
Responder		0	4	2
Acid titer		0	4	4
Antagonist		0	4	4
Conc_brain		0	4	2
Kimut/Kiwt		0	4	1
MTD/ TGI50		0	4	4
N20 formed		0	4	3
NAD+ level		0	4	1
S/CX Ratio		0	4	4
Tail flick		0	4	4
AMPA effect		0	4	2
Average max		0	4	1
DA/NE ratio		0	4	4
Haptoglobin		0	4	4
Hypokinesia		0	4	4
Intima area		0	4	1
LV dP/dtmax		0	4	4
NMDA effect		0	4	4
PFC/splleen		0	4	4
Penetration		0	4	1
Relative TS		0	4	4
[3H]-uptake		0	4	1
AB		0	4	1
BG		0	4	4
FD		0	4	4
T1		0	4	4
T4		0	4	2
Vv		0	4	4
kb		0	4	4
ko		0	4	1
ARP		0	4	1
C6h		0	4	4
C70		0	4	1
C90		0	4	1
FBA		0	4	4
IUP		0	4	1
IVR		0	4	4
K'i		0	4	1
KOH		0	4	2
Kd'		0	4	1
MAT	Mean absorption time	0	4	4
MDS		0	4	2
MND		0	4	2
MTA		0	4	1
NOL		0	4	4
SHR		0	4	1
TCI		0	4	4
c.v		0	4	1
k3'		0	4	1
nKa		0	4	4
AG80		0	4	1
C12h		0	4	1
C24h		0	4	2
C50k	Drug concentration needed to achieve 50% maximal killing rate	0	4	4
Clpl		0	4	1
DL50		0	4	1
EC60	Effective concentration for 60% activity	0	4	1
ECAR		0	4	1
ED97	Effective dose for 97% activity	0	4	2
F1/2		0	4	1
F3/4		0	4	1
Food		0	4	4
IC35	Inhibitory concentration for 35% acitivity	0	4	2
ID/g		0	4	4
IH50		0	4	2
KI50		0	4	2
Po/w		0	4	2
T3/4		0	4	1
TEWL		0	4	2
Test		0	4	4
kirr		0	4	1
pKa6		0	4	4
AUC 0		0	4	4
AUPAP	Area under the population analysis profile curve	0	4	4
CPmax		0	4	4
CTC50		0	4	2
Feces		0	4	4
Fluid		0	4	4
Ksolv		0	4	1
M/NTT		0	4	1
MEC50		0	4	1
MLC50	Minimum lethal Concentration for 50% activity	0	4	1
SPAV3		0	4	1
T.P.L		0	4	1
Venom		0	4	1
k eff		0	4	3
[3H] thymidine cpm/dish		0	3	3
Decrease in exit latency		0	3	3
Fraction cleared renally		0	3	3
Hydrolysis rate constant		0	3	2
SHR delta blood pressure		0	3	2
Survival increase (mean)		0	3	3
Concentration_unbound_brain		0	3	1
Duration of increase in SLA		0	3	1
Carnitine acetyl transferase		0	3	1
Difference in retention time		0	3	1
Mineralizing apposition rate		0	3	3
Presumed drug-related deaths		0	3	3
Amount of unreacted substrate		0	3	3
Mean free plasma concentration		0	3	3
Net log change in tumor burden		0	3	3
Topical irritation score(0-21)		0	3	2
Change in myocardial conduction		0	3	2
Homovanillic acid concentration		0	3	3
Mean total plasma concentration		0	3	3
Plasma concentration/IC50 ratio		0	3	1
Decrease of spontaneous firing rate		0	3	3
Susceptibilty Ratio (Liver/Intestine)		0	3	1
Ventricular relative refractory period		0	3	3
log10CFU/ml/day	log10 colony forming unit per 1 ml per day	0	3	3
Affinity state 1		0	3	1
Affinity state 2		0	3	1
Agonist efficacy		0	3	3
Bacterial growth		0	3	2
Hours above EC90		0	3	3
Loss of activity		0	3	3
Lysozyme release		0	3	1
Max displacement		0	3	1
Max jumping rate		0	3	2
Mean ulcer index		0	3	3
Protection ratio		0	3	3
Protective ratio		0	3	2
Superoxide anion		0	3	1
AUC glu reduction		0	3	3
Activation Factor		0	3	1
Average half life		0	3	2
No. of occlusions		0	3	2
Ratio_liver/blood		0	3	3
Toxicity (deaths)		0	3	1
Walking behaviour		0	3	3
Counts of rotation		0	3	3
Delta log10 CCID50		0	3	3
Glutathione levels		0	3	1
HSF activity x10e2		0	3	2
Met. stab. Cl. int		0	3	2
NaCl concentration		0	3	1
Palmitoyl-CoA oxid		0	3	3
Total liver weight		0	3	3
AUC first treatment		0	3	3
Average food intake		0	3	1
DOPAC concentration		0	3	3
Enoyl-CoA hydratase		0	3	3
Mortality threshold		0	3	2
Ratio_tumour/plasma		0	3	2
Skin Graft Survival		0	3	2
Therapeutic indices		0	3	1
AUC second treatment		0	3	3
Dioxygen uptake rate		0	3	1
Thromboxane B2 level		0	3	3
Thymus weight change		0	3	1
Acetylcholine release		0	3	1
Average sample intake		0	3	1
Elimination half-life		0	3	1
Mechanistic reference		0	3	1
Min plague Inhibitory		0	3	1
Relative peroxidation		0	3	2
Transfection activity		0	3	2
Uterine weight effect		0	3	1
Vasopressor responses		0	3	3
t1/2 unbound fraction		0	3	3
Cellular concentration		0	3	1
Day of vaginal opening		0	3	3
Decreased_triglyceride		0	3	2
Duration of anesthesia		0	3	1
Elevation of threshold		0	3	3
Prolactin release rate		0	3	2
Prostaglandin E2 level		0	3	3
Radioactivity in blood		0	3	3
Tumor weight reduction		0	3	2
Zinc finger reactivity		0	3	1
Cell plating efficiency		0	3	1
Cortical infarct volume		0	3	1
Cumulative urine volume		0	3	1
Paralysis		0	3	1
Paw edema		0	3	3
Plasma TC		0	3	3
Plasma TG		0	3	3
Serum TSH		0	3	3
TDS ratio		0	3	3
pKa value		0	3	1
Caco-2 A-B		0	3	1
Conduction		0	3	3
DOPA level		0	3	2
Hematocrit		0	3	1
Locomotion		0	3	3
Log Poct C		0	3	1
Mean index		0	3	1
Paw weight		0	3	2
T1/2 regen		0	3	1
Average IOP		0	3	1
Eosinophils		0	3	3
GR activity		0	3	3
Glutathione		0	3	3
NAD content		0	3	2
Neutrophils		0	3	3
Toxic index		0	3	1
pInhibition		0	3	3
([I]/[S]0.5)		0	3	1
Day of death		0	3	3
Femur weight		0	3	3
K cat/Kinact		0	3	2
NADH content		0	3	1
Ouabain dose		0	3	1
RNA fraction		0	3	1
log10cfu/day		0	3	3
%Bound_Plasma		0	3	3
Activity EC50		0	3	1
FPGS activity		0	3	3
Fold_increase		0	3	2
Grip strength		0	3	3
Learning time		0	3	2
Nucleic acids		0	3	3
Plasma_[5-FU]		0	3	3
TRAP staining		0	3	1
Thrombin time		0	3	2
Time in light		0	3	3
Traction test		0	3	3
Tumor latency		0	3	1
Tumour_[5-FU]		0	3	3
p24 synthesis		0	3	1
Basal activity		0	3	1
Drugabsorption	Drug absorption	0	3	1
Funbound_urine		0	3	3
GSH reactivity		0	3	1
Ki app (inact)		0	3	1
Pleural volume		0	3	3
Total coenzyme		0	3	1
Unbound plasma		0	3	3
Unchanged NDEA		0	3	2
B incorporation		0	3	1
Ion enhancement		0	3	1
Max aggregation		0	3	3
Overt behavoiur		0	3	3
Pregnancy index		0	3	3
Threshold value		0	3	1
Total clearance		0	3	1
Tumor incidence		0	3	1
AI	Atherogenic index	0	3	2
C1		0	3	2
RW		0	3	1
BAT		0	3	1
CIT		0	3	1
CR2		0	3	2
Eff		0	3	1
GAG		0	3	3
HVA		0	3	3
LPS		0	3	1
LRR		0	3	2
NAD		0	3	1
P/D		0	3	3
PAR		0	3	1
PSA		0	3	1
RPE		0	3	1
S/N		0	3	2
dPT		0	3	1
pkb		0	3	1
AUIC	Area under inhibitory curve	0	3	3
C120		0	3	1
CPCC		0	3	1
DLBT		0	3	2
Fana		0	3	1
ICL5		0	3	1
K SH		0	3	2
Kiso		0	3	3
Kkin		0	3	1
P7.4		0	3	3
PD'2		0	3	1
UC50	Drug concentration required for 50% unwinding of DNA	0	3	1
Vd/F		0	3	3
kred		0	3	1
pD10		0	3	2
pKic		0	3	1
AUC o		0	3	2
DOPAC		0	3	3
EF200		0	3	1
Empty		0	3	2
MTD/2		0	3	3
MTD/4		0	3	3
MTD/8		0	3	3
C5 min		0	3	3
CL(%Q)		0	3	1
f (po)		0	3	1
kONOO-		0	3	1
Ability		0	3	3
Alpha c		0	3	2
HR/chol		0	3	1
K amine		0	3	1
pKa app		0	3	2
sigmaSH		0	3	3
DDT msad		0	3	1
Improved		0	3	3
LV dP/dt		0	3	2
Mean AUC		0	3	3
RBA data		0	3	3
TSH/chol		0	3	1
Abolition		0	3	3
B/P ratio		0	3	2
CC50/IC50		0	3	1
Emesis_ED		0	3	1
GD200 [d]		0	3	3
MGDH GI50		0	3	3
Fraction excreted unchanged		0	2	2
Max inhibition concentration		0	2	2
Reduced_circadian_oscillation		0	2	2
Critical micelle concentration		0	2	1
Transporter deg rate const (k)		0	2	2
Transporter production rate (r)		0	2	2
Relative antiandrogenic activity		0	2	2
Average gross pathology scores+/- SE		0	2	2
Dose effecting a 15mmHg change in diastolic blood pressure		0	2	1
Therapeutic dose		0	2	1
Time to max. BSR		0	2	1
Time to righting		0	2	2
Bone damage score		0	2	2
Cmax_triphosphate		0	2	2
Contractile force		0	2	1
Correct responses		0	2	1
Max fold increase		0	2	1
NcoR1_recruitment		0	2	1
Rate acceleration		0	2	1
Arterial occlusion		0	2	2
Life span decrease		0	2	2
Max reversing rate		0	2	2
Mean time to death		0	2	1
Mean tumor latency		0	2	2
Permeability index		0	2	1
Rel brain exposure		0	2	1
Anogenital distance		0	2	2
Central selectivity		0	2	2
Delta logPoct-dod N		0	2	2
Food intake effects		0	2	1
Survivors at day 28		0	2	2
Time of peak action		0	2	1
Average tumor weight		0	2	2
Delta logDoct-dod7.4		0	2	1
Ke selectivity ratio		0	2	2
Left atrial pressure		0	2	2
Max mean weight loss		0	2	2
Non-specific binding		0	2	1
dpm bound to protein		0	2	1
Uterus to blood ratio		0	2	1
Weight change of AP-S		0	2	2
reduction in CL_renal		0	2	2
Antifertility activity		0	2	1
Average uterine weight		0	2	1
Carotid flow reduction		0	2	2
Change in DA synthesis		0	2	2
Complete survival dose		0	2	1
Days to tumor doubling		0	2	2
Group performance time		0	2	1
Induction of catalepsy		0	2	2
Radioactive absorption		0	2	2
Tumor volume reduction		0	2	2
Duration of peak action		0	2	1
Insulin lowering effect		0	2	2
Molar equivalence bound		0	2	1
Polymorphonuclear cells		0	2	2
Rate of [Ca+2] increase		0	2	1
Reduced_Cyp7a1_gene_exp		0	2	1
Reduced_Srebf1_gene_exp		0	2	1
Bioavailability Increase		0	2	2
Cytostatic concentration		0	2	1
Diastolic blood pressure		0	2	1
Parent remaining at time		0	2	2
Plasma [14C] cholesterol		0	2	2
Ratio_cerebellum/caudate		0	2	2
Ratio_cerebellum/putamen		0	2	2
[35S]-GTP-gammaS binding		0	2	1
Cardiac contractile force		0	2	2
Inhibition (alpha = 0.01)		0	2	2
Metabolic Bioavailability		0	2	2
Reduced_Serpine1_gene_exp		0	2	1
Degree of cross resistance		0	2	1
Relative stimulation index		0	2	1
CL_biliary		0	2	2
CSF levels		0	2	1
Cmax_ratio		0	2	2
Cr leakage		0	2	1
Excess MST		0	2	2
Gross kill		0	2	2
Kidney VDR		0	2	1
Log P/logD		0	2	2
Log Pdod N		0	2	1
Log Poct N		0	2	2
Log Poct Z		0	2	1
Media area		0	2	1
Resorption		0	2	2
T1/2 gamma		0	2	2
inhibition		0	2	2
ionization		0	2	1
Anti-emetic		0	2	2
H2 activity		0	2	2
LD50 x 1/10		0	2	1
LD50 x 1/20		0	2	1
LD50 x 1/40		0	2	1
OT interval		0	2	2
Occulations		0	2	2
Plasma Ca2+		0	2	1
Pro/Min/Enz		0	2	2
Stroke work		0	2	2
Tick action		0	2	1
-Delta G obs		0	2	1
Average GI50		0	2	2
Bactericidal		0	2	2
Cmax (Ratio)		0	2	2
Log Ddod 7.4		0	2	1
Median tumor		0	2	1
Weight ratio		0	2	2
ACAT activity		0	2	2
Brdu positive		0	2	2
Log10 EID50/g		0	2	2
Sedative dose		0	2	1
Seizure stage		0	2	2
Tissue weight		0	2	2
Anti-analgesic		0	2	2
Ca2+ excretion		0	2	1
Colonic weight		0	2	1
Gross log kill		0	2	2
Level in serum		0	2	2
Occlusion time		0	2	2
Serum LH level		0	2	1
Sublethal dose		0	2	2
Allodynia score		0	2	2
Blockade effect		0	2	2
IZ/AAR / AAR/LV		0	2	2
Striatal uptake		0	2	1
T/C (tumor vol)		0	2	2
Time to 30% BSR		0	2	2
Total glomeruli		0	2	2
(kcat/KM)/kuncat		0	2	2
Bacterial counts		0	2	2
Excreted glucose		0	2	2
Extraction ratio		0	2	1
Last therapy day		0	2	2
Max plasma level		0	2	1
Mean tumor delay		0	2	2
Solubility mg/ml		0	2	1
Stability of BSR		0	2	2
K ACT		0	2	1
K act		0	2	2
Kgmax	Rate constant for maximum microbial growth	0	2	2
Kiact		0	2	2
MC100	Minimal drug concentration causing 100% immobilization	0	2	2
PD 50		0	2	2
Rlung		0	2	2
SD200		0	2	1
SNGFR		0	2	2
Tonic		0	2	2
grade		0	2	1
k2/Ks		0	2	1
kIAM'		0	2	1
rel k		0	2	1
Clonic		0	2	2
Intake		0	2	1
Ka app		0	2	1
Log Ps		0	2	1
MTD/16		0	2	2
Min ID		0	2	1
Quench		0	2	1
Vinact		0	2	2
po AUC		0	2	2
1-logKi		0	2	1
ALT/GPT		0	2	1
AUC o-x		0	2	2
Avg AUC		0	2	1
CL rate		0	2	2
CL_Rate		0	2	1
Delta P		0	2	2
Exudate		0	2	1
F_urine		0	2	2
Log pKa		0	2	1
Max BSR		0	2	1
Mean KD		0	2	1
Mem Rec		0	2	2
P-value		0	2	2
kik0/Ki		0	2	1
log 1/C		0	2	2
-Log K B		0	2	2
Blockage		0	2	2
DA level		0	2	1
FPT msad		0	2	1
IUP AD50		0	2	2
K cat/Km		0	2	2
K second		0	2	1
LV DRxHR		0	2	1
Mean day		0	2	2
Molarity		0	2	1
Off-rate		0	2	1
Staining		0	2	2
Stenosis		0	2	1
Bile flow		0	2	1
ED50(app)	Apparent ED50	0	2	2
Elevation		0	2	2
IC50/EC50		0	2	2
ICdATP-50		0	2	1
K ass app		0	2	1
No change		0	2	2
Of tumors		0	2	2
POE score		0	2	2
Treatment		0	2	1
Turns/1st		0	2	2
alphat1/2	Primary phase half life	0	2	2
A2	Antagonist potency	0	2	1
EU		0	2	1
FB		0	2	1
GH		0	2	2
Hg	Sigmoidicity constant for drug effect on microbial growth	0	2	2
Hk	Sigmoidicity constant for microbial killing	0	2	2
IO		0	2	2
K4		0	2	1
LL		0	2	1
OT		0	2	2
PA	Permeability-surface area product	0	2	1
PR		0	2	1
PS		0	2	2
Ri		0	2	2
Vi	Volume of infusion	0	2	2
Ya		0	2	2
fm		0	2	2
fp		0	2	1
kp		0	2	1
ACR		0	2	1
AED		0	2	1
AHA		0	2	1
BQL		0	2	1
BSR		0	2	2
CLs		0	2	2
ClP		0	2	2
DPM		0	2	2
DUR		0	2	1
EDP		0	2	1
EIR		0	2	1
Fos		0	2	1
HED		0	2	1
HF2		0	2	1
I14		0	2	2
KbS		0	2	1
Kds		0	2	1
KiH	Inhibition constant for higher affinity site	0	2	1
KiL	Inhibition constant for lower affinity site	0	2	1
MIW		0	2	1
PKb		0	2	1
RTG		0	2	1
SLI		0	2	1
SPB		0	2	2
Sni		0	2	1
TTC		0	2	1
keq		0	2	2
%LBF		0	2	2
1/Ki		0	2	1
2T11		0	2	2
C50g	Drug concentration needed to achieve 50% effect on the maximum growth rate	0	2	2
CDOG		0	2	1
EF90		0	2	2
Poct		0	2	1
RVCF		0	2	2
SF50	dosage at which 50% of cells survived	0	2	2
TF/P		0	2	2
pKiH	-log (inhibition constant for higher affinity site)	0	2	1
pKiL	-log (inhibition constant for lower affinity site)	0	2	1
t0.9		0	2	1
APPTT		0	2	1
Brain		0	2	2
CLt/F	Apparent total clearance	0	2	1
CPD50		0	2	1
EIC50		0	2	2
Ratio_Cmax_brain/plasma		0	1	1
Spontaneous reperfusion		0	1	1
Ventricular tachycardia		0	1	1
Dose non renally cleared		0	1	1
Increase life span (Sur)		0	1	1
Max contractile activity		0	1	1
No effective/ no. tested		0	1	1
Chemosensitizing activity		0	1	1
Terminal elimination t1/2		0	1	1
Variation of edema volume		0	1	1
AUC glu reduction(mM x min)		0	1	1
Glucose lowering ob/ob dose		0	1	1
Intraocular pressure change		0	1	1
Relative contractile potency		0	1	1
Control at the dose of 5.0 ug/mouse		0	1	1
Control at the dose of 50.0 ug/mouse		0	1	1
Mean arterial blood pressure increase		0	1	1
Time of dosing before antigen challenge.		0	1	1
Glucose lowering relative to positive control		0	1	1
Plasma_insulin		0	1	1
Topical dosage		0	1	1
Toxicity index		0	1	1
Twitch tension		0	1	1
Acid hydrolysis		0	1	1
Delta non HDL-C		0	1	1
FRP at 10microM		0	1	1
Gastric lesions		0	1	1
Inhibitory dose		0	1	1
Median toxicity		0	1	1
Mortality ratio		0	1	1
Pharmacokinetic		0	1	1
Time after dose		0	1	1
Ultrafiltration		0	1	1
AUC extrapolated		0	1	1
Antihypertensive		0	1	1
Average log GI50		0	1	1
CSF/plasma ratio		0	1	1
Cytocidal effect		0	1	1
Ratio ED50/MIC50		0	1	1
Relative Vmax/Km		0	1	1
Resistance ratio		0	1	1
Tm shift degreeC		0	1	1
Volume reduction		0	1	1
Anabolic activity		0	1	1
Anti-HIV activity		0	1	1
Anxiolytic effect		0	1	1
Average bile flow		0	1	1
Cataleptic effect		0	1	1
Compound in urine		0	1	1
Photoxic reaction		0	1	1
Pressure response		0	1	1
Prolactin release		0	1	1
Recovered in bile		0	1	1
Tumour inhibition		0	1	1
AbA/analogue ratio		0	1	1
Clinical reference		0	1	1
Initial inhibition		0	1	1
Plasma_cholesterol		0	1	1
Rate of metabolism		0	1	1
Stimulatory effect		0	1	1
Synergistic effect		0	1	1
duration of action		0	1	1
Antagonist efficacy		0	1	1
Anticancer activity		0	1	1
Anxiolytic activity		0	1	1
Mean effective dose		0	1	1
Plasma_triglyceride		0	1	1
Reduced food intake		0	1	1
Concentration of Cl-		0	1	1
Infection score mean		0	1	1
Onset for sleep, min		0	1	1
Opsin shift activity		0	1	1
Permeability limited		0	1	1
Relative weight loss		0	1	1
Stimulatory activity		0	1	1
Intraperitoneal score		0	1	1
Relative inactivation		0	1	1
Funbound_adrenal_gland		0	1	1
Funbound_serum_albumin		0	1	1
Halucinogenic activity		0	1	1
Log of inhibitory zone		0	1	1
Radioactivity remained		0	1	1
IFN gamma concentration		0	1	1
Intrinsic		0	1	1
K inact/I		0	1	1
Locomotor		0	1	1
Max APD95		0	1	1
Oral dose		0	1	1
PActivity		0	1	1
T1/2 beta		0	1	1
Tmax/dose		0	1	1
Vmax (uM)		0	1	1
1/2Kcat/Km		0	1	1
5-HT Level		0	1	1
ET-1 level		0	1	1
GR control		0	1	1
Ki' uncomp		0	1	1
Log Poct A		0	1	1
P Increase		0	1	1
P-450 loss		0	1	1
Paw volume		0	1	1
T1/2 h/min		0	1	1
BSA binding		0	1	1
Molar ratio		0	1	1
Performance		0	1	1
Plasma_IL-6		0	1	1
Plasma_NEFA		0	1	1
Prlonged QT		0	1	1
REM latency		0	1	1
Replacement		0	1	1
Blood volume		0	1	1
Cell density		0	1	1
Dissociation		0	1	1
Funbound_fat		0	1	1
GI clearance		0	1	1
GI tolerance		0	1	1
Hypoglycemic		0	1	1
KD non ionic		0	1	1
Ki obs / [I]		0	1	1
Of viability		0	1	1
Range of MIC		0	1	1
Second order		0	1	1
Antipsychotic		0	1	1
Basal glucose		0	1	1
Control level		0	1	1
Fold Inc IC50		0	1	1
Max Reduction		0	1	1
NBT reduction		0	1	1
Plasma_leptin		0	1	1
SCW reduction		0	1	1
Sleep latency		0	1	1
Survival dose		0	1	1
T/C @ 20mg/kg		0	1	1
T/C @ 30mg/kg		0	1	1
T/C @ 40mg/kg		0	1	1
T/C @ 50mg/kg		0	1	1
Terminal t1/2		0	1	1
Weight (mg/g)		0	1	1
Activity_index	Ratio of inhibition zone of the test drug to standard drug	0	1	1
Adverse effect		0	1	1
Anti-arhythmic		0	1	1
Clearance (C1)		0	1	1
Curative Index		0	1	1
Generalization		0	1	1
Liphophilicity		0	1	1
Liver catalase		0	1	1
Plasma_glucose		0	1	1
ppKb		0	1	1
AD100		0	1	1
AFLCl		0	1	1
ECMax		0	1	1
ER/PR		0	1	1
Fmean		0	1	1
IC50H	IC50 for high affinity site	0	1	1
IC50L	IC50 for low affinity site	0	1	1
ID100		0	1	1
KdSPA		0	1	1
KdSPR		0	1	1
Ki/ki		0	1	1
LDH50		0	1	1
MIC97		0	1	1
MLogP		0	1	1
P app		0	1	1
PD' 2		0	1	1
TID20		0	1	1
k3/K1		0	1	1
tCmax	Time taken to achieve Cmax	0	1	1
2xAPTT		0	1	1
EC98.6		0	1	1
EC99.6		0	1	1
Killed		0	1	1
Log K4		0	1	1
Log KB		0	1	1
Log KZ		0	1	1
Log Ke		0	1	1
[Ca2+]		0	1	1
pKa AN		0	1	1
pKa AZ		0	1	1
pKa BN		0	1	1
pKa BZ		0	1	1
pKa E2		0	1	1
pRatio		0	1	1
Cp(f)ss		0	1	1
Effllux		0	1	1
Ki comp		0	1	1
Monomer		0	1	1
PCaco-2		0	1	1
Peak GH		0	1	1
T1/2 iv		0	1	1
Tm(app)	Apparent melting temperature	0	1	1
Vd area		0	1	1
Vel rem		0	1	1
f%T>MIC		0	1	1
kmax/KS		0	1	1
washout		0	1	1
%Cleared		0	1	1
Ccontrol		0	1	1
EFF+/-SD		0	1	1
F (%RSD)		0	1	1
GTPshift		0	1	1
ILSmaxOD		0	1	1
Ki inact		0	1	1
Log D7.5		0	1	1
Log Kill		0	1	1
No_cures		0	1	1
Relation		0	1	1
T1/2 h/s		0	1	1
pKd(app)		0	1	1
Fold IC50		0	1	1
GC200 [d]		0	1	1
Heme loss		0	1	1
L		0	1	1
I5		0	1	1
I7		0	1	1
IN		0	1	1
KD		0	1	1
KS		0	1	1
LA		0	1	1
QA		0	1	1
Ti		0	1	1
UV		0	1	1
V1		0	1	1
V2		0	1	1
VV		0	1	1
Vb		0	1	1
BBB	Blood brain barrier	0	1	1
CFR		0	1	1
CIp		0	1	1
Cls		0	1	1
Fez		0	1	1
I10		0	1	1
I13		0	1	1
I16		0	1	1
I20		0	1	1
I23		0	1	1
I28		0	1	1
I30		0	1	1
I42		0	1	1
ILA		0	1	1
K B		0	1	1
KNa		0	1	1
Kbb	Ratio of unbound fraction in blood to brain	0	1	1
Ki0		0	1	1
MPA		0	1	1
N/D		0	1	1
PAP		0	1	1
PLT		0	1	1
PkB		0	1	1
U/P		0	1	1
VSV		0	1	1
k12		0	1	1
k21		0	1	1
pCB		0	1	1
pKP		0	1	1
%AUC		0	1	1
1/Km		0	1	1
AD90	energy density necessary to induce apoptosis in 90% of the cells	0	1	1
CI50		0	1	1
EC14		0	1	1
EC16		0	1	1
EC91		0	1	1
ED58		0	1	1
HD40		0	1	1
IC33	Inhibitory concentration for 33% activity	0	1	1
ID60		0	1	1
K on		0	1	1
LD30		0	1	1
LD60	Lethal dose for 60% activity	0	1	1
LDLO		0	1	1
P50C		0	1	1
Pka2		0	1	1
V2/F		0	1	1
kmax		0	1	1
pK3'		0	1	1
pMax		0	1	1
